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Abstract	
	
The	last	century	has	seen	a	steady	increase	in	the	extension	of	the	average	lifespan.		This	has	
concomitantly	produced	higher	incidences	of	age-related	chronic	degenerative	diseases	like	Alzheimer’s	
and	Parkinson’s	diseases.		Age	is	the	single	greatest	risk	factor	for	the	development	of	not	just	these	
degenerative	conditions	but	cancer	as	well.		The	aged	niche	undergoes	a	number	of	maladaptive	
changes	that	allow	underlying	conditions	to	present	and	progress.		Exactly	which	changes,	contribute	to	
the	progression	of	which	disease	is	currently	an	area	of	intense	study.		However,	these	answers	often	
present	therapeutic	targets	for	disease	prevention.		Age	is	characterized	by	a	progressive	loss	of	tissue	
function	that	eventually	leads	to	the	death	of	the	organism.		At	the	cellular	level,	aged	tissues	are	
characterized	by	a	loss	of	resident	stem	cell	populations,	senescence,	and	low-grade	inflammation.		
While	aging	is	heterogeneous	in	terms	of	its	ultimate	effect	on	tissue	function	the	underlying	changes	
have	a	degree	of	overlap.		Cells	often	experience	increased	oxidative	stress	and	a	diminished	activity	in	
pathways	like	NRF2	whose	role	it	is	to	provide	resistance	to	such	stress.		Aged	cells	also	have	some	
change	in	their	overall	chromatin	and	nucleosome	structure	contributing	to	observable	changes	in	gene	
expression	and	regulation.		When	these	disruptions	occur	in	tissues	that	can	affect	the	larger	organism	
such	as	the	hypothalamus	they	affect	the	organism	as	a	whole	and	contribute	to	syndromes	seen	in	age	
such	as	insulin	resistance.		The	immune	system,	in	particular,	is	sensitive	to	both	the	cell-autonomous	
and	systematic	changes	that	occur	with	age.		Immune	and	endocrine	signaling	pathways	have	a	
considerable	amount	of	overlap,	and	mounting	evidence	points	to	the	role	of	inflammation	in	the	
metabolic	syndromes	that	occur	with	age.		Immune	dysfunction	in	the	CNS	has	a	special	significance	
because	of	the	dual	roles	of	microglia.		These	cells	exist	not	just	to	protect	against	foreign	invasion	but	
play	vital	roles	in	the	maintenance	of	brain	architecture	and	in	processes	central	to	cognition	like	long-
term	potentiation	and	the	differentiation	of	stem	cells	in	the	hippocampus.		The	aged	microglial	
phenotype	contributes	to	the	decline	that	occurs	normally	with	age	but	can	also	be	central	to	the	
progression	of	underlying	pathologies	including	several	degenerative	diseases.		Therapies	targeting	the	
maintenance	of	microglial	function	with	age	hold	the	potential	to	delay	disease	onset	and	possibly	
preserve	cognitive	function	further	into	life.	
Top-down	research	approaches	are	well	suited	for	the	study	of	interactions	between	complex	systems.		
The	rapid	improvement	of	mass	spectrometry	over	the	past	decade	has	allowed	researchers	to	examine	
more	complex	samples	with	fewer	preparation	steps	and	improved	accuracy.		This	approach	has	thus	far	
worked	very	well	in	the	study	of	aging	with	the	number	of	“Omics”	techniques	in	aging	models	
increasing	rapidly.		We	use	both	label-free	mass	spectrometry	and	the	more	traditional	real-time	PCR	to	
analyze	signaling	pathways	and	systems	in	both	tissue	homogenates	and	isolated	cells	from	aged	
animals.		By	analyzing	inflammatory	and	neurogenic	pathways	in	animals	treated	with	polyphenolic	
compounds	we	were	able	to	postulate	that	the	improved	behavioral	effect	of	these	compounds	is	likely	
related	to	the	decrease	of	pro-inflammatory	cytokines	and	a	restoration	of	WNT	signaling.		Proteomic	
analysis	of	aged	microglia	revealed	widespread	changes	in	chromatin	structure	and	cellular	machinery	
responsible	for	the	regulation	of	transcription.		In	addition,	we	uncovered	a	shift	in	the	underlying	
metabolic	state	of	aged	microglia	and	identified	several	pathways	upstream	of	these	changes.		These	
upstream	pathways	included	mTOR,	a	well-studied	nutrient	sensing	pathway	that	plays	a	role	in	
regulating	microglial	phenotype.		Modulation	of	identified	pathways	through	the	use	of	both	genetic	
(siRNA)	and	pharmacological	(allosteric	inhibitor)	was	able	to	recapitulate	the	aged	phenotype	in	normal	
cells,	confirming	the	role	of	these	pathways	in	pathological	changes.
	
	
	
	
	
Chapter	1:	Introduction	
1.1 The Four Layers of Aging 
The	old	adage	“Only	two	things	are	guaranteed,	death	and	taxes”	highlights	albeit	through	humor	a	
common	experience	that	afflicts	mankind,	age.		Until	recently,	and	still	even	in	the	halls	of	the	FDA	and	
most	medical	conferences	age	is	not	viewed	as	a	disease	but	a	naturally	occurring	process.	The	
deterioration	of	tissues	that	occurs	concurrently	with	the	aging	process	is	likely	a	requirement	for	the	
presentation	of	many	of	the	chronic	ailments	that	only	present	themselves	later	in	life.		The	three	most	
prevalent	causes	of	death	worldwide	cancer,	cardiovascular	disease,	and	dementia	all	boast	age	as	the	
single	largest	risk	factor	for	their	development	1.		Aging	has	been	characterized	at	every	biological	level	
and	its	effects	appear	to	be	tissue	specific.		This	is	not	to	suggest	however	that	the	underlying	
mechanisms	themselves	are	different,	just	that	at	the	tissue	and	organ	levels	the	manifestation	of	the	
lower	order	cellular	dysfunction	is	unique.		It	was	once	widely	held	that	oxidative	stress	was	a	primary	
driver	of	aging,	although	that	theory	is	currently	heavily	disputed.			
	
	Ran	Zhang,	in	his	review	The	four	layers	of	aging	outlines	the	four	primary	manifestations	of	age	at	each	
level	2.		The	first	layer	and	perhaps	the	most	obvious	is	the	decline	in	physical	and	cognitive	functions	
that	accompany	age.		The	decline	in	function	of	organ	systems	ultimately	leads	to	death	but	is	preceded	
by	a	degradation	of	tissue	function	and	dramatic	changes	in	composition.		In	the	CNS,	the	brain	
experiences	a	dramatic	loss	of	white	matter,	a	decrease	in	hippocampal	volume,	and		an	increase	in	the	
number	of	activated	immune	cells	3,4.		Similar	to	skeletal	muscle,	the	brain	experiences	a	decline	in	the	
number	and	proliferation	of	resident	stem	cells	5,6.		This	attrition	of	stem	cells	impairs	the	tissue	ability	
to	repair	itself	after	damage7.		Conflicting	reports	exist	as	to	whether	this	occurs	due	to	a	loss	in	the	
overall	stem	cell	population	or	a	reduction	in	their	proliferative	capacity	8-10.		A	confounding	factor	in	the	
resolution	of	this	question	is	the	difficulty	of	properly	identifying	a	neural	stem	cell.		Neural	stem	cells	
stain	for	several	glial	markers	and	there	is	further	debate	as	for	whether	astrocytes	themselves	can	
revert	back	to	a	“stem-like”	state	11,12.		Further	complicating	the	matter	is	the	quiescent	nature	of	resting	
stem	cells	in	which	they	express	no	proliferative	markers,	one	strong	identifier	of	the	stem	cell	
population	in	the	hippocampus.		While	the	causes	of	stem	cell	senescence	are	as	of	yet	not	definitive,	it	
occurs	systemically	in	every	stem	cell	niche	studied	13.	
The	second	layer	is	described	as	a	systemic	dysfunction	of	immune,	metabolic,	and	endocrine	systems.			
The	overall	effectiveness	of	the	peripheral	immune	system	declines	with	age,	resulting	in	a	greater	
susceptibility	to	infections	and	pathology.		This	is	true	for	both	the	innate	as	well	as	adaptive	branches.		
Age	coincides	with	a	reduced	responsiveness	and	loss	of	communication	between	all	immune	cell	types.		
The	overall	decline	in	reliability	of	the	immune	system	is	called	“immuno-senescence”	while	its	
contribution	to	the	aging	process	has	been	coined	“immuno-aging”	14,15.		The	etiology	of	this	dysfunction	
reflects	the	complexity	of	the	immune	system	itself	exhibiting	an	interplay	between	several	genetic	and	
cellular	components	16.	Mammalian	target	of	rapamycin	(mTOR)	is	perhaps	the	well-studied	pathway	in	
the	field	of	aging.		This	is	in	part	due	to	the	chance	discovery	of	the	relationship	between	the	mTOR	
inhibitor	rapamycin	and	its	effect	on	the	lifespan	of	organisms	across	several	species17.		mTOR	is	a	
central	regulator	of	cellular	energy	homeostasis	and	along	with	AMP-activated	protein	kinase	(AMPK)	17.		
mTOR’s	effect	on	longevity	is	believed	to	involve	its	regulation	of	insulin	signaling	and	autophagy	18.		In	
total	four	nutrient	sensing	pathways	are	deregulated	with	age:	Insulin/Insulin-like	growth	factor	
signaling,	mTOR,	AMPK,	and	Sirtuins	18-20.		Loss	of	regulation	of	these	critical	pathways	severely	impairs	
cellular	function	and	each	pathway	has	been	implicated	in	the	etiology	of	one	or	more	age-related	
pathologies	including	neurodegenerative	disease.		Recent	studies	have	shown	that	shifts	in	“metabolic	
flux”,	the	shuttling	of	intermediate	molecules	to	various	branches	of	energy	producing	pathways	occur	
in	mid-life	and	lead	to	mitochondrial	stress	and	eventual	damage	21,22.		Metabolic	and	Inflammatory	
have	considerable	overlap	in	the	signaling	pathways	utilized.		There	is	considerable	cross-talk	between	
NF-κB	and	the	insulin,	sirtuin,	AMPK,	and	mTOR	pathways	19,23-25.		Dysfunction	in	either	has	a	
compounding	effect	on	the	other	as	metabolic	and	inflammatory	signaling	are	tightly	intertwined.		The	
third	layer	of	aging	focuses	on	the	cells	themselves	and	the	disruptions	of	organelles	and	pathways	vital	
to	cellular	function.		The	mitochondria	have	the	single	largest	impact	on	age-dependent	dysfunction	
within	the	cell.		As	the	mitochondria	age,	they	produce	less	ATP	and	more	ROS	26.		Cellular	stress	
responses	like	NRF-1	and	NRF-2	respond	to	bioenergetics	stress	and	increased	ROS	respectively	27,28.		
During	acute	periods	of	activity,	these	stress	responses	restore	homeostasis	and	are	beneficial	to	the	
cell.		However,	chronic	activation	as	seen	in	age	can	impair	the	function	of	other	organelles	like	the	
endoplasmic	reticulum	29.		This	can	result	in	an	increase	in	misfolded	proteins	and	have	an	impact	on	
protein	translation	in	general.		Cellular	stress	signals	can	also	activate	NF-κB,	triggering	low-grade	
inflammation	and	eventually	apoptosis	29,30.		Increased	production	of	ROS	also	contributes	to	
accelerated	damage	to	DNA	and	other	organelles	31,32.		Nuclear	architecture,	as	well	as	the	cell	ability	to	
modify	the	chromatin	during	transcription,	is	heavily	reliant	on	the	NAD+	dependent	sirtuin	family	of	
histone	deacetylases	33.		Aged	cells	lose	their	ability	to	fold	their	chromatin	into	higher	order	structures	
and	epigenetic	regulation	becomes	impaired	as	the	composition	of	histones	changes	considerably	34.		
These	changes	lead	to	genomic	instability	that	along	with	the	decreased	effectiveness	of	DNA	repair	
enzymes	and	telomere	attrition	send	cells	into	a	senescent	state.		DNA-repair	deficient	models	have	
been	used	to	study	aging,	in	microglia,	these	models	recapitulate	a	convincing	amount	of	the	aged	
phenotype	35.			
Aging	is	a	complex	process	the	study	of	which	is	made	more	difficult	by	the	tissue-specific	nature	of	its	
effects.		The	effects	of	aging	on	a	particular	organ	are	the	result	of	the	cellular	composition	and	its	
interaction	with	the	multiple	deregulated	pathways	present	in	the	aged	niche.		While	the	analogy	of	
layers	provides	an	orderly	way	to	describe	aging	at	discrete	levels	it	may	falsely	imply	a	hierarchy	of	
causality	or	importance.		A	triggering	event	at	any	layer	can	lead	to	dysfunction	in	the	group	above	or	
below	it.			
1.1.2 Aging and Cognitive Decline 
The study of cognitive function with age is complicated by several confounding factors.  In 
humans, the expense of longitudinal studies means that most of the work has been cross-
sectional in nature introducing inter-person variability into results.  Further complicating the 
situation is the fact that age as a variable cannot itself be manipulated, as a consequence 
results are limited to being correlational in nature.  Finally, because age itself is a risk factor for 
degenerative diseases which until recently could not be confirmed until death, choosing a pure 
population was near impossible.  Despite these challenges, several studies over multiple 
decades have managed to provide insight into the impairments in cognitive function correlated 
with both normal and pathological aging.  Both human and non-human primates exhibit 
impairments in visual tasks like the delayed matching non-matching test which requires subjects 
to remember visual cues post a short (0-2 minute) delay 36.  Normal aging even in the optimum 
circumstances in correlated with a strong decline in the ability to encode new memories, 
working memory, and processing speed 36-38.  These deficits mirror those of animals with 
damage to the medial temporal lobe (hippocampus) suggesting that this area of the brain is 
highly sensitive to the effects of age 36,39.  The hippocampus is primarily thought of as central to 
spatial memory, however as the seminal study of the patient H.M. demonstrated it is also 
necessary for the encoding of new memory 36,40.  Both molecular and structural studies of the 
hippocampus show dramatic changes with age.  Not only does the hippocampus shrink with 
age, its resident stem cell niche located in the dentate gyrus is depleted 4,41.  Transcriptomic 
studies of the aged hippocampus reported an age-dependent decrease in trophic factors and a 
parallel increase pro-inflammatory cytokines IL-1β and TNFα 42.  The number and density of 
microglia staining for the activation marker MHC II are found in the aged hippocampus 4,43.  This is 
also true for patients with degenerative diseases like Alzheimer’s, although once again 
differentiating between disease and age effects in these cases can be difficult 44  The stem cell 
population in the dentate gyrus under normal circumstances provides new immature neurons to 
repopulate the CA3 region of the hippocampus, a process currently thought to be required for 
the formation of new memories 45.  Throughout the proliferation, migration, and eventual pruning 
of new neurons stem cells receive signals from both local neurons and microglia in the form of 
neurotrophins and chemokines 46,47.  Microglia themselves play a central role in initiating the 
proliferation of new neurons and pruning of synaptic connections during memory consolidation 
48.  This relationship comes to the forefront during aging when microglia themselves are 
impaired in their ability to adequately communicate with their environment and become highly 
reactive 46,48,49.  Increased levels of pro-inflammatory cytokines suppress both stem-cell 
proliferation and survival in the hippocampus of aged animals 49.  Similar to the consequences 
of a peripheral infection, this increase in cytokine activity impairs cognitive function by interfering 
with neurogenesis and synaptic plasticity 49.  
 Studies seeking interventions for this aging process have shown that blocking microglial activity 
with the antibiotic minocycline had beneficial effects on learning memory in rodents 50,51.  
Minocycline inhibits the NAPD oxidase enzyme, this enzyme is necessary for the extracellular 
ROS used to kill pathogens but also used as a key signaling component for the activation of 
NFκB 52.  Minocycline has also shown effectiveness in treating the cognitive decline associated 
with depression, which is also believe to have an underlying inflammatory component 51,52.  
Exercise also has a significant impact on attenuating age-dependent cognitive dysfunction 53.  
Exercise increases the levels of the trophic factor BDNF, which under normal circumstances is 
also secreted by microglia to promote synapse formation 47,53.  Exercise has been shown to 
increase blood flow to the hippocampus, attenuate age-dependent loss attrition, and improve 
spatial memory in aged rodents 53.  Another class of compounds with demonstrated 
effectiveness in improving memory in aged animals are polyphenols.  This side class of 
compounds found in several types of fruits and vegetables have shown promise in restoring the 
synaptic plasticity of aged animals 54,55.  Several mechanisms of actions have been proposed 
ranging from protection from oxidative stress to direct modulation of microglial function 54,56.  
The beneficial effects of these compounds are not limited to the brain as longitudinal studies 
have found benefits for a wide range of chronic diseases. 
 
1.1.3 Impact of Age on Genome Structure and Regulation 
Rare genetic disorders that cause an individual to appear much older than their actual age are 
known as progeroid syndromes.  These rare genetic disorders offer scientists the opportunity to 
study genes that appear to have a dramatic impact on the aging process in a unique way.  
There are a number of such syndromes including Werner, Rothmund-Thomson, and Ataxia-
Telangiectasia that have been widely studied 57.  These syndromes are commonly monogenic, 
meaning they arise from the mutation of a single gene, a gene which is involved in some way 
with DNA repair, the stability of chromatin, or the maintenance of the nuclear envelope 57.  
Patients with Werner syndrome experience skin atrophy, cataracts, osteoporosis, 
atherosclerosis, and cancer predisposition 58.  This syndrome is caused by a loss of function 
mutation in the WRN gene that encodes the RecQ Helicase.  This mutation leads to a high rate 
of somatic mutations in the DNA and increased chromatin instability 58.   
Maintenance of the Chromosomes is one of the most important jobs a cell performs throughout 
its lifetime, it is also one of the most difficult.  As we age there is not only an increase in 
molecules that can cause DNA damage e.g. reactive oxygen and nitrogen species, there is also 
a loss of functionality in enzymes responsible for DNA repair 59.  Aged cells have decreased 
efficiency in mismatch repair, base excision repair, and nucleotide excision repair 59.  In base 
excision repair, for example, there is not only an age-related decrease in the chromatin 
remodeling complex SWI/SNF but decreased enzymatic activity of several endonucleases 
including endonuclease III and AP endonuclease 1 (APE1) 59.  Change in the enzymatic activity itself 
may be a result of accumulated mutations in the gene, as has been shown in some studies of aged 
lymphocytes 60.  Gene expression patterns change significantly with age, however, the changes seem to be 
tissue specific 61,62.  One pattern that is consistent both across tissue and species is an increase in genes 
related to immune function and stress response 62.  In other cases these changes appear to be random, an 
increase in proteins only found in the brain in aged muscle 62.  This suggests that age is likely not a pre-
programmed set of changes but may be occurring as a result of dysfunctional genomic regulation.  
Chromatin structure and organization is vital for proper functioning and survival of any cell.  Higher 
order structures of chromosomes are made possible primarily by five families of histone proteins H1/H5, 
H2A, H2B, H3, and H4 63,64.  The interaction between histone proteins and DNA is vital for not just cell 
division and DNA compaction but for transcriptional regulation64.  Studies of transcriptional regulation 
have shown that groups of genes that are commonly transcribed together can exist on different 
chromosomes but are in close proximity to one another by virtue of histone modification 65,66.  There is a 
genome-wide shift in histone composition with a decrease in the H3 variant across tissues 63.  The sirtuin 
proteins play a large role in the maintenance of chromatin structure and the silencing of genes through 
epigenetic regulation 20.  A clear link between gene silencing and aging was made when a genetic screen 
found that a mutant SIR4 was found to increase lifespan by 40% in c. elegans 67.  This gain-of-function 
mutation prevented SIR4 from binding to telomeres abolishing silencing at that loci and increasing the 
levels of SIRs 2 and 3 in the nucleolus 67.  This emphasizes the importance of chromatin-modifying 
enzymes in the aging process and highlights the role of chromosome stability on lifespan.  Sirtuins and 
other histone modifying complexes lose activity as a part of normal aging, attenuating their ability to 
maintain proper genomic structure and thereby control 20,68.  The loss of function of these complexes is 
likely to have contributed heavily to the age-dependent changes in transcription seen across species. 
 
1.1.4 Energy Metabolism and Nutrient Sensing Pathways 
The insulin/IGF signaling pathway or IIS is named as such because insulin and IGF-1 elicit 
similar, yet not identical, cellular responses.  While insulin is produced by the pancreas IGF is a 
part of the somatotrophic axis which includes growth hormone (GH) and IGF which is produced 
in cells as a response to GH 69.  The regulation of aging by IIS is the most conserved in 
evolution and is upstream of other pathways heavily involved in aging like FOXO and mTOR 
19,70.  Consequently, mutations that reduce the activity of the IIS axis or downstream proteins 
like mTOR have been linked to longevity 18,71.  The impact of deregulated bioenergetics 
signaling and specifically nutrient sensing is best demonstrated by the well-studied benefit of 
dietary restriction on longevity72.  Mice lacking the insulin receptor in adipose tissue had 
extended lifespans 73.  A paradox exists within the study of the IIS and its role in the aging 
process.  One possible explanation is the during normal aging cells downregulate insulin 
signaling as an attempt to slow cellular growth and extend lifespan.  Although in some progeroid 
syndromes treatment with IGF ameliorates some effects of the disease 57.  
 Among the lifespan, relevant downstream effectors of IIS are the FOXO family of proteins.  
These evolutionarily conserved proteins play a role in regulating energy metabolism and 
processes like glycolysis in the liver 74.  They are also important mediators of several stress 
response pathways and are capable of halting the cell cycle and sending cells into apoptosis 
70,75,76.  FOXO proteins are downstream of PI3K and regulated by AKT activity through 
phosphorylation, but can also be regulated by acetylation and deacetylation by the sirtuin class 
of HDAC’s 75.  The activity of the FOXO proteins is heavily regulated and largely controlled by 
crosstalk among upstream pathways integrating stress, nutrient, and growth signals.  The role of 
FOXO’s is heavily context dependent but its role in maintaining cellular function during diverse 
types of stress makes this class of proteins an important cellular quality control measure.  
FOXO’s role in longevity may have to do with its regulation of pathways like NRF-2.  FOXO3 is 
upstream of NRF-2, an antioxidant response gene that upregulates several ROS neutralizing 
enzymes 27.  In mice, FOXO1 acts as a tumor suppressor and can halt the cell cycle and even 
initiate apoptosis in response to excessive DNA damage 77.  These activities, however, are 
dependent upon regulating enzymes like SIRT1 whose activity is known to decrease with age 
77,78. 
The mammalian target of rapamycin (mTOR) and AMP Kinase (AMPK) are the two main energy 
sensing pathways in the cell.  mTOR exists in two distinct complexes, mTORC1 and mTORC2.  
While both contain the mtor catalytic core, they possess different subunits, which may contribute 
to differences in activity .79.  mTOR regulates a very wide network of genes involved in several 
areas of energy metabolism including autophagy 80.  Inhibition of mTOR signaling extends 
lifespan and research have shown that downregulation of mTOR is likely one leg of how dietary 
restriction extends lifespan 18.  C.elegans with a mutant form of mTORC1 received no additional 
lifespan benefit from the dietary restriction 18  These studies refer to the downregulation of 
mTORC1 as low levels of mTORC2 are detrimental organism’s survival.  Extended inhibition of 
both complexes of mTOR causes impaired wound healing and insulin resistance in mice 18,81.  It 
is believed that it is the effect of prolonged rapamycin treatment on mTORC2 that mediates the 
majority of these negative effects 82,83.Inhibition of the mTORC1 target S6K1 also extends 
lifespan and it appears to a relevant target of mTORC1 in terms of its effects on longevity 18.  
S6K1 is a kinase responsible for the initiation of translation and acts by phosphorylating 
ribosomes 80.  MTOR also affects mitochondrial function through the regulation of fatty acid 
metabolism through pgc 1α 80. MTOR’s other important role in longevity is the regulation of 
autophagy or the degradation of macromolecular components during periods of nutrient scarcity 
1,84,85.  mTORC1 is an inhibitor of autophagy, and upregulation of autophagy is necessary for the 
longevity increasing effects of mTORC1 inhibition84.  Autophagy assists in the clearing of 
cellular debris, misfolded proteins, poorly functioning organelles, which in the case of 
mitochondria is term mitophagy 85. 
AMPK is the primary sensor of nutrient scarcity.  Upregulation of AMPK suppresses mTOR 
signaling and increases autophagy 86.  The upregulation of AMPK signaling is indicative of 
healthy aging.  Metformin, a drug commonly prescribed for diabetics and may also increase 
lifespan, although conflicting reports have been published.   One way it may accomplish this is 
by through upregulation of AMPK 87.  Interestingly it was recently discovered that FOXO is a 
direct target of AMPK 87.  During dietary restriction, FOXO transcription is increased in an AMPK 
dependent manner and later phosphorylated by the kinase 87.  It is believed that FOXO is the 
mechanism by which AMPK is able to induce stress resistance during periods of nutrient 
scarcity. 
1.1.5 Immune System Dysfunction  
“Inflammation describes low-grade chronic inflammation in the absence of overt infection (“sterile” 
inflammation) and is a significant risk factor for both morbidity and mortality in elderly people” 88.  The 
mild increases in pro-inflammatory cytokines like IL-6 and molecules like C - reactive protein that 
characterize the aged environment are associated with and predictive several age-related diseases.  
Increased levels of inflammatory markers are correlated with changes in body composition, 
immunosenescence, and metabolic syndromes 1,88.  Increased inflammation in adipose tissue is associated 
with obesity, diabetes mellitus, and insulin resistance 89,90.   
Normally inflammation is a beneficial process that facilitates removal of pathogens, protection after 
traumatic events, and tissue repair and turnover.  However, these acute responses appear to be impaired in 
the aged individual.  A common example of immune dysfunction with aging is the prolonged sickness 
response that accompanies an illness or injury in an elderly individual 91.  This extended period of 
cognitive deficits and lethargy is due to the microglial response of the CNS failing to transition through 
the normal inflammatory cascade from upregulation to inactivation 91.  This prolonged period of activity 
exacerbates cellular stress in the local environment, leads to excessive cell death, and inadequately 
restores homeostasis post injury 91.  This propensity for prolonged and exaggerated responses to acute 
stimuli has been referred to as “priming”.  Although this term is misleading in the full context of age-
related immune dysfunction.  The chronic inflammation present in the elderly is usually low-level and 
persistent vs the exaggerated state has seen in “primed” cells.  This is one example of innate immune cell 
dysfunction with age, however, examples go far beyond microglia.  Phagocytosis, chemotaxis, superoxide 
production and signal transduction is impaired across all cell types 15.  Importantly, macrophages and 
dendritic cells have impairments in the antigen presentation capability, a necessity for the amplification of 
the adaptive response.  Only macrophages have an increase in a mediator of inflammation, PGE2 while 
production of other cytokines appears to be reduced.  In addition, there appear to be alterations in the 
expression of the Toll-Like Receptor family in macrophages 92.  Most studies have focused exclusively 
treatment with LPS and TLR4 pathway.  These studies have shown an increased expression of TNFα, 
IL1β, and IL6, and a more general decrease in cytokine expression through TLR’s 2,6,3,5 92.  Thus, it 
appears that the age-related dysfunction of the innate immune system may be antigen specific as well as 
cell specific. 
In addition to changes in the innate system, the adaptive immune system undergoes drastic changes with 
age as well.  There is an age-dependent decline in the efficiency of humoral immune response 
characterized by lower numbers of high-affinity antibodies, weaker antibody responses, and less IgG class 
switching 93,94.  The homing of B-cells to secondary lymphoid organs is also diminished with age 94.  In 
addition to decreased proliferation, they also have a decreased ability to increase their receptor affinity 
through somatic hyper mutation 94.  While in T cells, during aging there is a shift from naïve to memory T 
cells in the periphery 95.  T cells from aged animals exhibit reduced proliferation, differentiation, and 
cytokine production 95.  T cell responses are delayed in old mice with lower overall levels of intensity.  
The perfect storm of decreased antigen presentation from the innate system and a lack of adequate 
response from T-cells which are necessary for the correct polarization of other immune cells lead to an 
inadequate response to pathogens or damage.  While these cells fail to mount responses to normal danger 
signals they improperly respond to self-antigens resulting in an on-going inflammatory response. 
  While the cause of this chronic inflammation is not fully understood several contributing factors have 
been identified.  One likely culprit is the leukocytes themselves whose reactive molecules over a lifetime 
degrade and damage the structural elements of the surrounding tissue.  This damaged tissue would 
produce molecules capable of activating more immune cells producing an on-going inflammatory 
response96.  Parallel to this is the fact that the phagocytic capability of microglia and macrophages are 
limited, this would leave open the possibility of incomplete debris clearance from sites of inflammation 97.  
One feature of aged macrophages and microglia is diminished phagocytic capacity meaning the immune 
system is less equipped to deal with the clearance of cells 98.  Self-debris can mimic “Pamps” or pathogen 
associated molecular patterns for which innate immune cells have receptors that trigger their polarization 
to pro-inflammatory phenotype 99.  Other molecules within cells like RNA, ATP, fatty acids and HMGB1 
are recognized by the cells inflammasome and are capable of activating nearby immune cells 99.  Another 
theory is that metabolites of the guts resident microbes begin to leak into the periphery contributing to 
low-grade inflammation. 
1.2.1 The Microglial Cell  
Two	decades	ago	microglia	would	have	been	described	simply	as	the	resident	innate	immune	cell	of	the	
CNS.		Today,	it	is	hard	to	truly	understand	the	identity	of	this	versatile	and	mission	critical	cell	that	make	
up	between	10-15%	of	the	adult	brain.		These	cells	play	critical	roles	in	the	brain	starting	at	development	
as	part	of	the	symphony	of	cell	types	that	orchestrate	the	architecture	of	the	brain46.		Post	development,	
they	continue	to	shape	our	“cognitive	world”	as	they	play	a	role	in	the	structure	and	function	of	synaptic	
connections46.		Microglia	are	generally	thought	to	be	derived	from	myeloid	progenitors	that	migrate	to	
the	CNS	during	development100.		This	was	confirmed	when	the	CNS	of	PU.1	null	mice	were	devoid	of	
microglia101.		PU.1	is	a	family	of	transcription	factors	necessary	for	the	terminal	differentiation	of	cells	in	
the	myeloid	lineage	101.		
Understanding	the	morphology	of	microglia	is	central	to	understanding	their	function.		In	the	absence	of	
some	inflammatory	event,	microglia	are	said	to	exist	in	a	“resting”	state.		The	term	resting,	however,	is	
both	inaccurate	and	misleading.		In	the	normal	healthy	brain,	microglia	has	small	somas	and	a	highly	
“ramified”	morphology	with	finely	branched	projections	100.		These	projections	are	one	reason	why	the	
term	resting	is	inaccurate.		Two-photon	imaging	has	shown	that	these	projections	are	highly	dynamic	
and	constantly	moving	surveying	the	environment	102.		The	unique	position	of	microglia	in	the	CNS	
requires	this	specialized	cell	to	behave	in	a	far	different	fashion	than	classic	macrophages.		For	one	the	
complement	of	receptors	present	must	be	able	to	respond	to	a	unique	set	of	stimuli	native	to	the	CNS.		
This	branches	on	microglia	are	not	only	in	contact	with	the	synapses	but	possess	receptors	for	
neurotransmitters	including	the	GluR	receptor	as	well	as	receptors	like	P2X	and	P2Y	which	detect	ATP	
and	are	involved	in	neuropathic	pain	102,103.		Glutamate	is	released	in	excess	during	neuronal	damage	
and	can	serve	as	a	“danger”	signal	from	neurons	to	microglia102.		While	microglia	will	rarely	come	in	
contact	with	bacteria	they	are	more	likely	to	encounter	viral	infections	and	tissue	damage.		In	addition	
to	molecules	like	ATP	microglia	are	activated	by	components	of	serum	like	fibrinogen	which	may	
indicate	a	breach	of	the	BBB	102.		Their	unique	combination	of	receptors	reflects	the	unique	needs	of	
their	environment.			
Maintenance	of	the	microglial	“steady-state”	is	important	for	the	homeostasis	of	the	CNS.		Their	
interaction	with	neighboring	cells	one	way	their	pro-inflammatory	activity	is	kept	at	bay	48.		Microglia	
expresses	a	range	of	receptors	that	are	constitutively	stimulated	by	components	released	from	neurons	
or	astrocytes	48.		CD200R	and	CXC3R1	are	two	example	of	inhibitory	receptors	expressed	on	microglia	
104,105.		Loss	of	CXC3R1,	also	known	as	fractalkine	increases	the	number	of	MHC	II microglia, an indicator 
of increased activation 105.		Phagocytosis	of	damaged	cells	is	an	important	role	for	microglia.		Several	
receptors	play	a	role	in	this	process	including	FCgamma	and	CR3106.		The	CR3	complement	receptor	does	
not	require	activation	of	the	adaptive	immune	system	and	plays	a	role	in	synaptic	plasticity	and	pruning	
107,108.		Beth	Stevens	at	Harvard	has	reported	that	defective	CR3	signaling	may	lead	to	inappropriate	
synaptic	pruning	and	early	synapse	loss	in	Alzheimer’s	mouse	models	109.	The	TREM2	receptor	has	
received	attention	for	its	role	in	phagocytosis	of	amyloid	plaques	and	its	ability	to	down	regulate	the	
inflammatory	signaling	cascade	110.		Some	variants	of	TREM2	have	been	associated	with	increased	risk	
for	Alzheimer’s	disease	and	inefficient	removal	of	amyloid	plaques	110.		In	addition	to	its	role	in	
phagocytosing	amyloid	TREM2	also	sustains	the	microglial	response	to	demyelination	ensuring	adequate	
clearance	110.		
When	describing	the	characteristics	of	activated	microglia	it	is	helpful	to	refer	to	the	well-defined	
activation	states	of	macrophages.	Although	this	approach	is	also	too	simplistic.		Macrophage	activation	
states	correlate	directly	to	the	T-cell	effector	program	that	elicits	that	response.		The	M1	state	which	can	
be	triggered	by	LPS	or	IFNγ	which	is	released	by	TH1	T-cells	111.		This	state	is	characterized	by	increases	in	
pro-inflammatory	cytokines	and	the	release	of	reactive	oxygen	and	nitrogen	species111.		The	M2	state	is	
elicited	by	IL-4/IL13	(M2a),	Immune	complexes/IL1	(M2b),	or	a	range	of	immunomodulatory	molecules	
including	IL10/IL17,	glucocorticoids,	and	TGF-β	111,112.		Microglia,	on	the	other	hand,	do	not	follow	these	
pathways	precisely	and	exist	on	an	axis	of	surveillance	to	the	effector.		This	may	partially	be	because	of	
the	diverse	range	of	signals	they	receive,	the	sensitive	nature	of	the	tissue	that	they	occupy,	and	the	lack	
of	amplifying	cells	in	the	vicinity.		In	any	case,	the	phenotype	of	microglia	is	considered	repressed	when	
compared	to	that	of	macrophages.		Microglia	do	in	general	possess	both	classical	and	alternative	
activations	whose	roles	mimic	that	of	macrophages	113.		During	acute	inflammatory	events	microglia	
increase	levels	of	reactive	oxygen	and	nitrogen	species	as	well	as	cytokines	and	eicosanoids	113.		The	
levels	released	are	generally	lower	than	that	seen	in	macrophages	with	a	shorter	duration.		This	reduces	
the	collateral	damage	to	nearby	networks	of	neurons	and	astrocytes.		While	the	acute	release	of	pro-
inflammatory	cytokines	is	generally	perceived	as	detrimental	low	levels	of	IL1B	and	IL6	actually	increase	
neurogenesis	and	enhance	LTP	108.		During	the	alternative	activation	of	microglia	low	levels	of	pro-
inflammatory	cytokines	are	actually	released	demonstrating	the	diverse	role	of	these	molecules	114.		The	
M2a	alternative	activation	state	of	microglia	is	responsible	for	the	necessary	neurotrophic	support	that	
improves	cell	survival	post	an	acute	inflammatory	event	114,115.		The	microglial	cell	is	one	of	the	most	
diverse	cells	in	biology.		It	plays	a	central	role	in	the	functioning	of	the	CNS	throughout	life	and	the	
consequences	of	their	dysfunction	contribute	to	a	wide	number	of	diseases.		 
1.2.3 Aged Microglia  
As	we	have	just	discussed	the	microglia	of	the	CNS	are	much	more	than	a	resident	macrophage.		They	
help	to	orchestrate	neurogenesis,	maintain	synaptic	plasticity,	and	enhance	cell	survival	during	stress	
47,108,116,117.		Nearly	every	neurodegenerative	disease	has	microglial	dysfunction	as	some	aspect	of	its	
etiology118.		Cellular	aging	has	a	profound	effect	on	the	function	of	microglia,	partly	due	to	their	long-
lived	nature.		Dysfunction	of	these	cells	significantly	alters	the	neuronal	environment	and	contributes	to	
a	decline	in	cognitive	function	116.	A	low-grade	chronic	inflammatory	state	like	that	of	the	periphery	is	
characteristic	of	the	aged	CNS.		Several	studies	have	found	elevated	levels	of	IL1β,	IL6,	TGFβ,	and	TNFα	
in	the	aged	CNS	along	with	diminished	levels	of	IL-10119,120.	Microglia	in	the	aged	brain	express	higher	
levels	of	MHC	II and have dystrophic morphologies with fewer branches and lower overall motility 121,122. 	
There	is	no	consensus	on	how	aging	affects	microglial	proliferation,	with	some	studies	reporting	
increased	numbers	of	microglia	in	the	aged	brain	and	other	contradicting	this	claim.		What	is	clear	is	that	
a	larger	proportion	of	these	cells	are	in	some	state	of	activation	and	have	increased	expression	of	the	
scavenger	receptor	MHCII which may or may not directly indicate a pro-inflammatory state.		Another	
point	of	debate	is	the	phagocytic	ability	of	aged	microglia.		Some	groups	have	found	that	aged	microglia	
have	large	inclusions	of	ingested	myelin	and	fail	to	adequately	clear	debris	after	injury123.		Other	groups	
have	found	no	such	deficit	in	this	ability,	although	the	difference	is	likely	due	to	the	models	used	and	
methods	of	observation.		In	addition	to	the	MHC	receptor	CD68,	CD11B,	CD86,	and	a	range	of	TLR’s	are	
all	upregulated	in	aged	microglia	and	reflect	the	pro-inflammatory	status	of	these	cells103.		Both	humans	
and	rodents	have	a	prolonged	“sickness	response”	after	peripheral	infection	91.		In	mice,	aged	microglia	
produce	higher	levels	of	cytokines	for	an	extended	period	of	time	post-TLR4	activation,	although	
responses	to	TLR2	and	9	appear	to	be	diminished	124,125.		This	prolonged	activation	state	and	
exaggerated	release	of	cytokines	were	first	termed	“priming”.		The	term	priming	was	a	carryover	from	
experiments	in	macrophages	demonstrating	that	exposure	to	subthreshold	levels	of	the	cytokine	IFNγ	
followed	by	subsequent	exposure	to	adequate	stimuli	produced	an	exaggerated	response	126,127.		First	
described	in	1983	both	the	underlying	mechanism	and	the	end	phenotype	of	“priming”	differ	quite	
substantially	that	of	aged	microglia.	In	addition	to	exaggerated	pro-inflammatory	responses,	microglia	
exhibit	a	loss	of	responsivity	to	anti-inflammatory	molecules	including	IL4,	glucocorticoids,	and	the	
immunomodulatory	cytokine	TGFβ	91,128.		While	there	does	not	appear	to	be	a	loss	of	receptor	density	
on	the	cell	surface	it	does	appear	that	signal	transduction	is	impaired	in	aged	microglia	91.		While	there	is	
no	noticeable	decrease	in	IL4	receptors	the	composition	or	“mix”	of	surface	receptors	change	
dramatically	as	microglia	age	103.		One	study	demonstrated	a	decrease	in	receptors	for	pathogen	
response	and	an	increase	in	receptors	for	cellular	damage	such	as	those	that	detect	purines,	lipids,	and	
RNA	103.		This	may	represent	an	adaptive	response	to	aging	that	is	aimed	at	preventing	cellular	damage	
while	increasing	tissue	repair.	Microglia	must	be	able	to	migrate	to	a	site	of	injury	and	respond	based	on	
the	danger	signals	present	at	that	location.	Aged	microglia	show	impaired	motility	and	diminished	
response	to	chemokines	121.		They	also	show	decreased	activity	of	their	processes	whose	primary	
responsibility	is	the	surveillance	of	the	synapse	121.			These	changes	likely	contribute	to	the	diminished	
synaptic	plasticity	observed	with	age.		If	microglia	have	a	reduced	ability	to	interact	with	the	synapse	
than	they	are	less	likely	to	produce	timely	trophic	support	decreasing	the	resiliency	of	the	CNS	to	stress.		
The	receptors	responsible	for	maintaining	microglia	in	their	“quiescent	state”	decrease	with	age	46,48.	
Mouse	models	have	shown	that	decreased	CD200	or	Fractalkine	receptor	increases	the	number	of	
activated	microglia	in	the	brain	as	demonstrated	by	loss	of	their	ramified	morphology	and	expression	of	
markers	of	activation	104,105.			
Beyond	changes	in	their	environment	that	contribute	to	a	loss	of	their	quiescent	state	microglia	undergo	
cell-autonomous	changes	that	contribute	to	their	dysfunction	with	age.		By	mid-life	microglia	switch	
from	utilizing	glucose	as	a	primary	energy	source	to	fatty	acids	and	ketones	in	a	process	related	to	the	
“Randle-cycle”	first	described	in	1994	129,130.		These	less	efficient	substrates	lead	to	increased	ROS	
production	in	microglia	and	elevated	levels	of	oxidative	stress	which	have	been	shown	to	contribute	to	
microglial	dysfunction	31,119.		Oxidative	stress	is	not	just	capable	of	activating	the	NLRP3	inflammasome	
but	can	chronic	stress	can	lead	to	endoplasmic	reticulum	damage	compromising	protein	translation	
131,132.		Microglia	experience	aging	in	a	similar	fashion	to	other	cell	types,	diminished	DNA	repair	
capacity,	a	reduced	response	to	oxidative	stress,	and	alterations	in	transcriptional	and	translation	
regulation.		All	of	these	factors	likely	converge	to	produce	the	phenotype	seen	in	the	aged	brain.		No	
one	factor	is	likely	to	be	causative	for	the	entirety	of	the	phenotype.	However,	if	pathways	relevant	to	
important	aspects	of	function	like	trophic	support	and	pro-inflammatory	signaling	can	be	identified,	
meaningful	therapies	may	result.	
1.2.4 Microglia in Neurodegenerative Disease  
The	presence	of	activated	microglia	has	been	described	in	almost	every	neurodegenerative	disease	
studied	44.		An	important	area	of	inquiry	has	centered	on	whether	or	not	this	activation	is	a	result	of	an	
on-going	disease	process	or	is	complicit	in	the	onset	of	the	disease	itself.		Studies	in	Alzheimer’s	have	
shown	that	activation	of	microglia	occurs	early	in	the	disease	process	and	may	contribute	to	early	
impairments	in	cognitive	function	133.		Further	investigation	revealed	that	the	on-going	release	of	TNFα	
from	microglia	contributed	to	the	death	of	neurons	in	a	mouse	model	of	Alzheimer’s	109,133.		However	
separate	studies	have	shown	that	microglia	are	necessary	for	the	phagocytosis	of	amyloid	and	loss	of	
these	cells	exacerbates	amyloid	deposition	and	oxidative	stress	in	the	hippocampus	134.		One	
longitudinal	study	concluded	that	use	of	some	over	the	counter	anti-inflammatory	treatments	was	
effective	in	delaying	disease	onset	but	showed	no	benefit	in	patients	who	had	already	presented	
symptoms	135.		Microglial	activation	can	impair	neurogenesis,	disrupt	LTP,	and	contribute	to	symptoms	
of	diseases	like	depression	44,125.		One	theory	regarding	Alzheimer’s	is	that	inadequate	removal	of	
plaques	contributes	to	a	chronic	inflammatory	response	which	increases	the	speed	of	neuronal	death.		
Another	is	that	the	microglia	reach	a	phagocytic	capacity	and	simply	become	senescent	failing	to	
provide	adequate	trophic	support	to	sustain	neurons	in	their	environment.				There	is	likely	an	
intersection	between	aging	and	the	disease	process	itself.		The	connection	between	Alzheimer’s	and	
Neuroinflammation,	however,	is	undeniable.		Massive	genomic	studies	aiming	to	identify	risk	factors	for	
Alzheimer’s	uncovered	a	number	of	genes	expressed	microglia	and	involved	in	the	inflammatory	
response	136.		One	such	gene	is	TREM2	a	protein	involved	in	phagocytosis	which	has	since	been	found	to	
be	necessary	for	the	adequate	removal	of	amyloid	110.		Under	normal	circumstances	deposition	of	
amyloid	may	not	lead	to	advanced	neuronal	death,	this	may,	in	fact,	be	the	case	through	most	of	midlife	
when	amyloid	deposition	is	thought	to	begin.		It	is,	therefore,	important	to	understand	exactly	which	
age-related	changes	occur	in	microglia	that	makes	the	brain	susceptible	to	the	disease	process.	
Alzheimer’s	is	not	the	only	neurodegenerative	disease	characterized	by	either	misfolded	proteins	or	a	
heightened	requirement	for	the	phagocytic	activity	of	microglia.		Parkinson’s	disease	is	characterized	by	
deposition	of	the	alpha-synuclein	which	aggregates	and	is	cytotoxic	to	neurons	137.		Like	amyloid,	alpha-
synuclein	is	capable	of	triggering	an	inflammatory	response	in	the	CNS.		Mouse	models	of	Parkinson’s	
including	MPTP	and	6-OHDA	use	toxins	to	mimic	the	cell	death	seen	in	the	substansia	nigra	in	
Parkinson’s	disease	138.		Studies	examining	the	role	of	microglia	knocked	out	the	TLR4	receptor	prior	to	
treatment	with	MPTP	and	showed	reduced	cell	death	in	the	localized	area	139.		These	models	suggest	
that	indeed	microglia	do	contribute	to	the	cell	death	observed	post	treatment.		However,	their	
relevance	to	the	disease	process	itself	is	still	in	question.		Complete	deactivation	of	microglia	can	
exacerbate	phenotype	by	inhibiting	the	removal	of	apoptotic	cells	and	debris.		Co-cultures	of	microglia	
and	neurons	have	demonstrated	that	iNOS	released	from	microglia	can	increase	the	nitration	of	alpha-
synuclein	leading	to	greater	aggregation	and	subsequently	increasing	toxicity	towards	neurons	140.		The	
interplays	between	aging	microglia	and	various	disease	processes	are	complex	but	are	quickly	being	
dissected	as	strides	are	made	towards	therapies.		
1.3.1 Regulation of Neuroinflammation in the CNS 
The	immune	response	is	orchestrated	by	several	cell	types	including	leukocytes	and	endothelial	cells.		
Even	in	the	CNS	several	cell	types	including	the	neurons	themselves	play	a	role	in	the	regulation	of	acute	
inflammation.		Despite	the	BBB	creating	a	virtual	shield	between	the	CNS	and	the	periphery,	there	is	a	
great	deal	of	cross-talk	between	the	two	immune	systems.		Activation	of	the	peripheral	immune	system	
is	sufficient	to	trigger	and	acute	reaction	in	the	CNS	as	cytokines	traverse	the	BBB	and	trigger	responses	
in	astrocytes	and	microglia	141.		In	fact,	an	acute	peripheral	infection	is	sufficient	to	trigger	a	disruption	
and	neurogenesis	and	diminished	cognitive	function	known	as	the	“sickness”	response	141.		When	
inflammation	originates	in	the	CNS	cytokines	signaling	through	the	hypothalamus	cause	organism-wide	
changes	in	metabolism	and	immune	function	142.		In	addition,	cytokines	released	during	an	acute	
episode	trigger	the	endothelial	cells	in	the	BBB	to	form	loose	junctions	allowing	the	infiltration	of	
peripheral	cells	into	the	CNS	143.		Peripheral	cells	particularly	T-cells	infiltrate	and	amplify	the	local	
response	under	circumstances	where	an	adaptive	response	is	required	143.		Acute	responses	in	the	CNS	
rarely	occur	for	more	than	a	few	hours	and	require	an	enhanced	response	resulting	from	the	infiltration	
of	peripheral	leukocytes.		However,	during	disease	or	chronic	inflammatory	signaling,	there	is	evidence	
of	excessive	infiltration	occurring	resulting	in	damage	to	the	CNS	environment	141.		In	addition,	the	
movement	of	leukocytes	into	the	brain	is	also	facilitated	by	chemokines	In	particular	CCL19	and	CCL21	
which	attract	T	cells	to	the	BBB.	
The	activation	states	of	microglia	are	governed	to	a	great	degree	by	their	interaction	with	surrounding	
neurons.		However,	the	cytokines	released	by	microglia	exert	a	number	of	powerful	effects	on	all	cell	
types	in	the	CNS.		TNFα	and	IL1β	are	two	of	the	most	abundant	cytokines	released	during	an	
inflammatory	response	144.		At	an	intracellular	level,	IL1β	initiates	a	number	of	critical	intracellular	
signaling	cascades	including	the	P38	MAPK	pathway.		This	stress-activated	signaling	pathway	is	a	
juncture	between	cell	survival	and	cell	death	and	upregulates	the	inflammatory	response	in	leukocytes	
145.		An	important	chemokine	during	inflammatory	events	is	MCP-1	or	macrophage	chemoattractant	
protein	1.		It	plays	a	role	in	attracting	microglia	and	astrocytes	to	the	site	of	infection,	but	may	also	
disrupt	neuronal	function	146.		Complement	proteins	are	also	an	important	part	of	the	inflammatory	
response	in	the	CNS.		In	addition	to	their	roles	in	lysing	pathogens,	they	are	also	important	for	the	
clearance	of	debris	during	phagocytosis	107.		FCγ	mediated	phagocytosis	requires	opsonization	by	
complement	and	is	a	primary	route	by	which	pathogens	and	aggregated	proteins	are	removed	from	the	
milieu	147.	
1.3.2 Consequences of Neuroinflammation 
Some	levels	of	the	cytokines	TNFα	and	IL1β	are	beneficial	and	support	synaptic	plasticity	148.		Elevated	
levels,	however,	disrupt	cognitive	function,	impair	LTP,	and	can	lead	to	long-term	changes	in	brain	
architecture	149.		IL1β	can	lead	to	the	loss	of	synaptic	connection	as	a	result	of	increased	neuronal	
sensitivity	to	glutamate.		In	vitro	studies	have	shown	that	IL6,	TNFα,	and	IL-18	can	trigger	the	death	of	
neuronal	cells	in	culture150.		Nitric	Oxide	is	another	compound	released	during	inflammation	that	can	
trigger	cell	death	in	neurons	by	inhibiting	cellular	respiration.		These	effects	on	neuronal	cells	extend	to	
the	neural	stem	cells	which	reside	in	the	hippocampus	and	the	nostril	migratory	stream	of	the	forebrain	
151.		Evidence	suggests	that	declining	neurogenesis	contributes	to	the	cognitive	deficits	seen	both	in	age	
and	the	early	stages	of	neurodegenerative	disease.		This	decline	can	be	directly	attributed	to	the	
increase	in	activated	microglia	present	in	the	hippocampus	as	previously	discussed.		IL-1β	inhibits	the	
WNT/β-Catenin	pathway	in	neural	stem	cells,	blocking	a	primary	driver	of	cellular	proliferation	152.		
Inhibition	of	IL1β	in	the	brains	of	aged	animals	restores	neurogenesis	and	improves	cognitive	function.		
Inflammation	has	also	been	implicated	in	the	cognitive	deficits	experienced	in	depression	51.		
Minocycline,	a	commonly	prescribed	antibiotic	inhibits	NADH	oxidase	attenuating	microglial	activation.		
When	this	drug	was	given	to	rats	in	a	mouse	model	of	depression,	symptoms	abated	51.		The	researchers	
attributed	this	benefit	with	a	decrease	in	interferon-alpha.		Other	diseases	are	not	beginning	to	be	
considered	consequences	of	microglial	dysfunction.		Microglia	are	now	being	considered	as	major	
contributors	to	epilepsy	and	schizophrenia,	as	these	diseases	are	becoming	attributable	to	faulty	
synaptic	pruning	153,154.		The	consequences	of	Neuroinflammation	extend	beyond	the	CNS,	inflammation	
in	the	brain	contributes	to	the	“metabolic	syndrome”	commonly	seen	in	elderly	individuals.		Persistent	
inflammation	can	drive	changes	in	metabolically	active	tissues	specifically	in	adipose	tissue	and	liver.	
Insulin	sensitivity,	glucose	intolerance,	obesity,	and	hypertension	are	all	symptoms	of	this	metabolic	
syndrome	that	occurs	partly	as	a	result	of	increased	IL1β	and	TNFα	circulation	in	the	blood	155.		The	
hypothalamus	plays	a	central	role	in	maintaining	this	metabolic	syndrome.		Chronic	overnutrition	can	
disrupt	neurohormonal	balance	and	lead	to	a	propagation	of	obesity	and	other	disorders	155.		The	
mediobasal	hypothalamus	is	a	central	regulator	of	energy	homeostasis	and	is	comprised	of	two	principal	
types	of	neurons	which	are	sensitive	to	the	activation	of	the	IKKβ/NFkβ	axis.		Activation	of	this	pathway	
in	these	neurons	impairs	adequate	nutrient	sensing	capability	drive	a	loss	of	their	ability	to	maintain	a	
system	wide	homeostatic	environment	155.		In	addition	to	NFkβ,	c-JUN	and	MYD88	signaling	pathways	
are	also	linked	to	increased	obesity	in	animals	155.	
1.3.3 Neuroinflammation in Degenerative disease 
The	progression	of	most	neurodegenerative	diseases	involves	a	worsening	and	persistent	inflammatory	
component.		The	increase	in	cytokine	and	reactive	species	has	direct	effects	on	various	aspects	of	the	
disease	pathology.		Chronic	inflammation	leads	to	an	increase	in	both	amyloid	precursor	protein	(APP)	
synthesis	and	tau	phosphorylation	133.		Inflammatory	cytokines	initiate	APP	cleavage	in	MAPK	dependent	
manner.		Another	study	demonstrated	that	TNFα	can	increase	amyloid	deposition	by	increasing	BACE-1	
transcription	133.		The	role	of	tau	in	disease	etiology	is	still	being	fully	elucidated	but	its	connection	with	
Neuroinflammation	is	clear.		Tau	phosphorylation	increases	with	age	and	can	be	increased	as	a	result	of	
microglial	activation	156.		Activation	of	microglia	with	LPS	in	culture	increases	the	phosphorylation	of	tau	
with	co-cultured	neurons	156.		It	is	hypothesized	that	IL1β	through	the	P38	mapk	pathway	is	responsible	
for	this	increase	in	phosphorylation	157.		Multiple	Sclerosis	(MS)	is	an	example	of	a	disease	driven	by	the	
adaptive	and	not	innate	immune	system.		This	disease	is	characterized	by	progressive	demyelination	and	
inflammation.		MS	is	the	result	of	a	compounded	adaptive	response	primarily	TH1	and	TH17	T	cells	and	
to	a	lesser	extent	B	cells	143,158.		Macrophages	and	to	a	smaller	extent	microglia	are	driven	by	the	IFNγ	
released	by	these	T	cells	resulting	in	damage	to	exposed	axons	and	limited	phagocytosis.		This	may	in	
part	play	a	role	in	the	progressive	nature	of	the	disease	as	these	innate	cells	begin	to	present	myelin	
oligodendrocyte	basic	protein	MOBP	to	adaptive	cells	as	an	activating	marker.		This	feedback	loop	of	cell	
damage	and	inflammatory	amplification	is	a	hallmark	of	the	CNS	environment	during	disease	
progression.	
1.4 Commonly Used Microglial Models  
The role of microglia in both neurodegenerative disease and the normal cognitive decline has 
made studying them a top priority across the neurobiology fields.  Central to this are the 
development and refinement of models of a microglial function under healthy circumstances and 
in disease states.  Much work has been done thus far on both of these fronts.  The in vivo study 
of microglia in healthy tissue is straightforward as they express several markers of the myeloid 
lineage and share many common receptors with macrophages including CD11b and IBA1 144.  
Other in vivo measurements have included two-photon microscopy for the study of neuronal 
microglia interaction and GFP-labeled microglia utilizing a myeloid specific promoter to drive 
expression 121,159.  The same characteristics that make microglia easy to study in the healthy 
brain create complexity in disease states.  In both aging and disease, there is a disruption of the 
blood-brain barrier (BBB) and an invasion of circulating monocytes into the brain 143.  
Differentiation of microglia and peripheral macrophages generally relies on differing expression 
levels of the same marker.  For example, microglia is CD11B high CD45low, this provides 
slightly more than a subjective measure of the difference in the population in most cases.  
Outside of highly sensitive experiments like flow cytometry making this distinction is quite 
difficult.  The same difficulty exists when using genetic methods that rely on myeloid-specific 
promoters that are often shared between macrophages and microglia.  There has been some 
success driving microglial-specific expression using the fractalkine promoter 160.  The drawback 
to this approach is that the relative size of the fractalkine promoter limits the genes capable of 
being expressed in this manner.  Furthermore, fractalkine expression decreases with age which 
may confound studies using aged mice.   
Despite these challenges several useful models for studying microglia both in vivo and in vitro 
have been developed.  In vitro cell models include primary extraction and culturing of cells from 
either neonatal or adult animals 144,161.  Certain techniques have been developed for the 
isolation of “amoeboid” microglia from the cortex of neonatal mice that produce a 95% pure 
culture of cells 161.  The benefit of this technique is that the cells tend to behave as they did in 
vivo demonstrating phagocytic activity as well as an upregulation of cytokines in response to 
IFNγ and TNFα 162.  These cells were also able to produce NO and other reactive species when 
challenged.  The major challenges of these preparations are the time and investment necessary 
for a relatively small biological sample.  Immortalized cell lines include the BV2 and N9 lines 162.  
The BV2 line shows a high degree of similarity to primary microglia both in the expression of cell 
surface markers and in upregulation of cytokines in response to the challenge 163.  There is 90% 
overlap between the genes expressed by primary microglia and those expressed by BV2 cells in 
response to the challenge 163.  However, the immortalized cell line has a lower expression level 
of most cytokines when compared to primary cells 163.  While immortalized cell lines are widely 
used their applicability as a model is limited when compared to that of primary cells by virtue of 
the cancer genes they contain.  
Some models seek to study the role of microglia in disease by removing them from the equation 
completely.  One way this is accomplished is by knocking out the PU.1 family of transcription 
factors which are necessary for the terminal differentiation of myeloid cells164.  It is important to 
note that this produces an animal that lacks all cells of the myeloid lineage including peripheral 
macrophages.  This may or may not become a confounding factor in the subsequent study.  
Another model that produced an aged like phenotype is the DNA-repair deficient model.  
1.5 Omics Analysis of Microglia 
A number of studies have been completed examining the gene and protein expression in the 
aged brain 16.  In multiple diseases and aging models and under varying contexts these studies 
have revealed vital information about the state of the CNS.  However, it is difficult to precisely 
correlate changes observed with a given cell type in most of these studies.  Even in the case of 
genes only expressed in immune cells the difficulty of differentiating between microglia and 
invading macrophages in a particular disease model can confound inferences.  Despite these 
challenges, some labs have produced in-depth reports about the changes in the transcriptome 
of aged microglia.  Perhaps the most in-depth study to date was performed by the El-Khoury lab 
who performed an RNA-sequencing analysis comparing aged microglia and macrophages.  
They found that the transcriptome of microglia and macrophages varied in somewhat interesting 
ways.  Microglia express receptors more highly specialized for detection of self-antigens than 
macrophages do.  They also found that pathways involved in oxidative phosphorylation were 
downregulated while those involved in pro-inflammatory signaling were downregulated 103.  This 
directly contradicts reports of increased microglial activation and higher level pro-inflammatory 
cytokines in the aged brain.  However, there possible explanations for the discrepancy.  
Upregulation of MHCII is commonly used as a marker for activation but it may not necessarily correlate 
with a pro-inflammatory phenotype.  This marker is expressed on M2 macrophages as well as M1 and 
quiescent microglia have also been detected while expressing this marker 144.  Higher levels of cytokines 
could also occur as a result of macrophage infiltration or activation of astrocytes.  However, ex vivo 
studies have confirmed that at least in terms of activation by TLR4, aged microglia do in fact secrete 
higher, not lower levels of cytokines in response to activation.  The El Khoury group also claimed that 
they’re data showed a decrease in markers of classical activation and an upregulation of markers of 
alternative activation.  Once again this directly contradicts numerous previous reports of increased 
inflammatory pathway activity in aged microglia. 
  In a proteomic analysis of aged rat microglia that had been classically and alternatively activated the 
Stevens lab showed higher enrichment of proteins involved NAPDH oxidase activity.  In their 
experiment, the Stevens lab utilized SILAC based mass spectrometry to examine the activation states of 
young and aged primary microglia.  They observed activation of pathways governing ROS/RNS, MIF-
mediated inflammation, and Fcγ mediated phagocytosis 165.  In addition, there were significantly altered 
pathways like those downstream of NFE2l2, the NRF2 pathway involved in the resistance to oxidative 
stress.  While there were increased levels of pro-inflammatory pathways the fact that phagocytic activity 
was increased is confounding.  Phagocytosis is generally thought of as an activity of alternatively 
activated microglia.  It is possible that aged microglia fall into a previously undefined area of the 
activation spectrum.  Or that the age-dependent dysfunction results in improper polarization of the cells.  
Earlier studies of microglia in vivo also observed gene expression changes that seem to suggest higher, 
not lower expression of inflammatory cytokines and chemokines in aged microglia.  The Lee lab 
examined isolated microglia post injections with cocktails designed to elicit either an M1 or M2 response 
in young and old animals 166.  They found that upon exposure to the M1 cocktail aged microglia released 
higher amounts pro-inflammatory genes but the M2 response of aged microglia was compromised.  
Whatever the differences in the models used, there is still a lack of clarity as to the true state of microglia 
in the aged brain.  Adding to the confusion is the heterogeneity of the microglial populations throughout 
the brain.  Retinal microglia exhibit a significantly different transcription profile than do microglia found 
in the cortex or hippocampus 167.  This transcriptional profile extends beyond the receptor complement 
and into the inflammatory response itself.  So aging amongst these cells is likely going to exhibit some 
localized variability.   
1.6 Hypothesis and Objectives 
Neuroinflammation is a major component of the age-related increase in risk for neurodegenerative disease 
and cognitive decline [5]. The primary contributor to neuroinflammation is the priming of microglia in the 
aged brain [5]. The term priming refers to the increased response of microglia to pro- inflammatory 
stimuli and the decreased response to anti-inflammatory or regenerative activation states [1]. In addition 
to an altered inflammatory profile, microglia show an impaired ability to maintain homeostasis in the 
neurogenic niche and can impair neurogenesis and proper formation of synapse [6]. This detrimental 
effect on neurogenesis and synaptic plasticity contributes to impaired LTP and eventual decline of 
hippocampal-dependent memory function [7]. In addition primed microglia contribute to the progression 
of several neurodegenerative diseases and may be responsible for part of the decline in cognitive function 
that accompanies these disease [8]. Addressing the inflammatory component of the degenerative disease 
is vital to slowing their progression. However, our current understanding of the regulation of polarization 
and of how aging contributes to the priming of microglia is limited, hampering the development of 
successful therapies targeting the inflammatory component of degenerative diseases. The goal of this 
research is to improve our understanding how age-dependent changes in microglial cellular processes 
contribute to the primed phenotype. 
Neurogenesis in the subgranular zone of the hippocampus contributes to long-term spatial memory 
formation as well as neural plasticity [9]. Decreases in neurogenesis occur as individual’s age and have 
been attributed to both a decreased number of progenitors as well as a decreased proliferative rate [10]. 
Inflammatory cytokines like TNFα, IL6, and IL-1βhave been shown to attenuate the proliferative rate of 
stem cells and shift differentiation away from neuronal towards glial [11]. In addition, increased 
inflammatory signaling has been implicated as the cause of decreased neurogenesis in models of 
neurodegenerative disease [12]. In young animals, microglia exerts a positive influence over neurogenesis 
increasing the proliferative rate and contributing to proper synaptic functioning through pruning and 
phagocytosis of apoptotic cells [2]. A hallmark of the primed microglia is a decline in these homeostatic 
functions and increased secretion of pro- inflammatory cytokines which attenuate progenitor proliferation 
and survival [8]. Thus, a critical focus of this research is the hypothesis that modulating microglial 
phenotype exerts an influence over the neurogenic niche and therefore cognitive function. 
 A challenging aspect of identifying the causes of microglial priming is a poor understanding of the 
mechanisms that regulate macrophage/microglial polarization. While the effects of various cytokines on 
activation states have been studied extensively, the diversity of signaling mechanisms by which these 
activation states are established is still not fully understood. We have identified two potential regulators of 
the primed phenotype using targeted PCR arrays and proteomics. These two regulatory targets are 
nutrient sensing pathways including mTORC2 and a blunted glucocorticoid response. 
Nutrient sensing pathways as regulators of polarization and effects of priming: In an attempt to discover 
regulators of microglial priming we performed a proteomic analysis of microglia isolated from young and 
old C57BL/6 mice (see preliminary data). One upstream regulator identified in using Ingenuity Pathway 
Analysis™ (IPA) of our Super-SILAC data set was inhibition of RICTOR.  RICTOR is a central 
component of the mammalian target of rapamycin (mTOR) C2 complex, which is one-half of the mTOR 
signaling pathway. The role of mTOR in aging has been extensively studied [13, 14] and rapamycin 
which primarily inhibits mTORC1 extends lifespan in many species including mice 13.The role of 
mTORC2 in aging, however, is less well understood. Lifespan studies in C. Elegans demonstrate that 
while inhibition of mTORC1 extends lifespan inhibition of mTORC2 shortens it [16]. While it has been 
demonstrated that mTOR signaling can modulate macrophage polarization and response to stimuli, the 
extent, and mechanism of activity is still in the early stages of discovery. The role of mTORC2 on 
inflammation is emerging. Given inhibition of RICTOR in macrophages results in increased 
inflammatory signaling in response to LPS 168, we predict a similar effect in microglia, however, the role 
of mTORC2 vs mTORC1 in microglia has not been delineated. The literature thus supports the 
hypothesis that nutrient sensing pathways play a regulatory role in macrophage/microglial polarization. It 
is, therefore, imperative to understand how these pathways may change with age and what the 
consequences of those changes may be. In our preliminary data, we performed siRNA knockdown of 
RICTOR in BV2 microglial cells and this was sufficient to cause a blunted response to IL4, an M2 
activator. Currently, no data exists on altered mTORC2 signaling in aging and its contribution to priming 
but our data suggests that it may be a central regulator of this phenotype. In addition outlining a more 
detailed mechanism of mTORC2 complexes and their role in microglial polarization will contribute to our 
understanding of microglial dynamics and the involvement of nutrient sensing pathways in the regulation 
of inflammation. 
1.7 Summary of Projects 
Current attempts at addressing the inflammatory component of the degenerative disease have yielded little 
in the way of positive results of patients suffering from these diseases.  One reason for this is a poor 
understanding of the molecular drivers of inflammation in the CNS with age.  Complete deactivation of 
microglia has been shown to exacerbate phenotype and simply reducing the production of ROS/RNS 
through an inhibition of NADPH oxidase is insufficient to sufficiently reduce cell death.  What is needed 
is a method by which we can modulate microglial phenotype returning them to their neuroprotective 
surveillance state and restore their ability to attain the alternative activation state.  The findings contained 
in this dissertation outline methods by which natural compounds can be used to this end.  Natural 
methods of intervention already exist that have been shown to be effective at modulating microglial 
activity and reducing the inflammatory response.  We further highlight the mTORC2 pathway as a central 
actor in the pseudo-classical activation of aged microglia.  Thus producing both a target and potential 
treatment by which microglial activity can be influenced during the course of the disease. 	  
	
	
	
	
	
Chapter	2		
Methods	
2.1 Cell Culture and Treatments 
Primary	microglia	were	grown	in	base	media	of	DMEM	supplemented	with	F12,	10%	heat-inactivated	
fetal	bovine	serum,	glutamine	(glutamax	2mM),	100	µg/ml	penicillin,	and	100	U/ml	streptomycin.		Cells	
were	allowed	3	days	in	culture,	at	which	time,	dendritic	arbors	representative	of	a	resting	phenotype	
were	easily	discernible.		BV2	microglial	cells	were	used	to	obtain	the	heavy	labeled	protein	groups.		
These	cells	were	supplemented	with	either	100	µg/ml	each	of	heavy	13C6L-lysine	and	12C6L-arginine	or	
100	µg/ml	each	of	unlabeled	L-arginine	and	L-lysine	(Cambridge	Isotope).		The	labeling	procedure	
allowed	for	>99%	incorporation	of	the	amino	acid	labels	into	the	microglial	proteome.		For	phosho	
studies,	cells	were	cultured	overnight	in	DMEM	as	described	above	with	only	1%	FBS.		After	serum	
starvation	cells	were	treated	with	100	ng/ml	IGF	in	serum	free	media	for	10,	30,	and	60	minutes	prior	to	
lysis	with	RIPA	buffer	supplemented	with	calyculin	a	and	protease	inhibitors.		For	westerns	assessing	
phenotypes	cells	were	cultured	overnight	in	1%	FBS	DMEM.		Cells	were	subsequently	treated	with	20	
ng/ml	TNFα	and	IL-4	(Sigma)	for	24	hours.			
	
2.2 RT-PCR Arrays and Assays 
Tissues	were	 removed	 and	microdissected	 to	 isolate	 the	hippocampus.	 	 Samples	were	 snap	 frozen	 in	
liquid	nitrogen	and	stored	at	-80	degrees	C	until	homogenization.	Total	RNA	was	isolated	from	tissue	of	
adult	 rat	 hippocampus	 using	 RNeasy	 mini	 kit	 (Qiagen,	 Valencia,	 CA,	 USA).	 	 Quantitative	 RT-PCR	 was	
performed	using	DNA	Engine	Opticon	2©	(Bio-rad	Hercules,	CA)withMulti-stage	program	parameters	as	
follows:	10	min	at	95C,	40	cycles	of	15	s	at	95C	and	1	min	at	60C.		Samples	were	tested	in	triplicate,	and	
the	samples	obtained	from	three	to	five	independent	tissues	were	used	for	the	analysis	of	relative	gene	
expression	using	 the	2−ΔΔCT	method.	 	 The	 following	PCR	arrays	were	utilized	 for	 this	 study.PI3K/AKT	
pathway	 PARN-058Z,	 WNT	 signaling	 targets	 array	 PARN-243Z,	 Cytokine	 and	 Chemokine	 array	 PARN-
150Z	 (Qiagen,	 Valencia,	 CA).	 	 These	 arrays	 contain	 primers	 corresponding	 to	 84	 genes	 related	 to	 the	
individual	pathways,	five	housekeeping	genes	for	normalization,	and	positive	and	negative	controls	for	
the	PCR	reaction.		Genes	were	considered	to	be	differentially	expressed	if	their	expression	differed	by	at	
least	twofold	between	the	young	and	old	or	old	and	old	supplemented	groups,	and	that	difference	was	
statistically	significant	across	replicates	p<.05.	
After	treatment	as	described	above	cells	were	lysed	and	RNA	was	collected	using	the	rn-easy	plus	kit	
(qiagen).		Concentration	and	quality	were	determined	using	a	nano	drop	analyzer	(thermo).		100	nano	
grams	of	rna	was	with	vilo	superscript	cdna	reverse	transcription	mix	(Thermo)	to	create	a	cdna	
template.		Rt-pcr	was	performed	using	the	power	up	sybr	green	mastermix	(Applied	Biosystems)	on	a	
step-one	plus	real-time	pcr	machine	(Applied	Biosystems).		The	following	“fast”	cycling	conditions	were	
used:	2	minutes	50°,	1	minute	95°C,	95°C	15	seconds,	60°C	3	seconds	with	read,	this	was	repeated	for	40	
cycles	followed	by	a	melt	curve.		The	primers	used	were	TNFα,	IL1β,	IL6,	MARCO,	ARG1,	IGF1,	ACTB,	and	
YM1	(IDT	Primetime	Primers,	ref	seq	NM_013693,	NM_008361,	NM_031168,	NM_010766,	NM_007482,	
NM_1055770,	NM_009892)	at	a	concentration	of	500	nM.	
	
2.3 Primary Cell Isolation 
Primary	microglia	were	obtained	from	young	(3-5)	month	and	old	(22-24)	month	old	animals.		Mice	were	
euthanized	with	CO2	according	to	IACUC	standard	protocol.		A	single	cell	suspension	was	obtained	using	
Miltenyi	Biotec’s	neural	tissue	disassociation	kit	(P)	(130-093-231).	Briefly,	brains	were	removed	and	
placed	in	cold	HBSS	w/o	ca+	mg+	ice.		Using	a	scalpel	the	brains	were	mechanically	disassociated	in	a	
petri	dish	then	transferred	to	a	15	ml	tube	and	spun	at	200g	for	two	minutes.		The	tissue	was	
enzymatically	digested	according	to	manufacturer’s	protocol	to	obtain	a	single	cell	suspension.		Primary	
microglia	were	isolated	using	Miltenyi	Biotec’s	LS	magnetic	columns	and	CD11b	magnetic	beads	
(130042401	and	130093634	respectively).			This	procedure	yielded	between	200k	and	300k	cells	with	
95%	purity	as	confirmed	by	ICC.			
2.4 Mass Spectrometry 
Prior	to	lysis	cells	were	washed	with	PBS	and	collected	with	a	rubber	cell	scraper.		Cells	were	then	lysed	
in	4%	SDS	in	100mM	Tris-HCL,	pH	7.6	and	100	mM	dithiothreitol	at	95°C	for	four	minutes.		Protein	
concentration	was	determined	using	the	660	nm	Protein	Assay	supplemented	with	Ionic	Detergent	
Compatibility	Reagent	(Fisher).		Samples	underwent	buffer	exchange	and	digestion	utilizing	the	FASP	
method.		Briefly,	cells	were	exchanged	into	9	M	urea	and	alkylated	with	10	mM	iodoacetamide	in	a	30	
kDa	Microcon	Forensic	Column	(Millipore)	across	multiple	14,000xg	centrifugations	prior	to	exchange	
into	25	mM	ammonium	bicarbonate.		Proteins	were	digested	overnight	using	a	1:100	ratio	of	Mass	
Spectrometry	Grade,	TPCK-treated	trypsin	(Promega)	prior	to	collection	into	a	new	tube.		Samples	were	
desalted	on	C18	SPE	columns.		Samples	were	concentrated	in	a	vacuum	concentrator	prior	to	
resuspension	for	strong	cation	exchange	fractionation.		Samples	were	fractionated	on	a	U3000	offline	
HPLC	fitted	with	a	200	mmx1	mm	I.D.	polysulfoethyl	strong	cation	exchange	column	employing	a	
gradient	of	10	mM	ammonium	formate	to	200	mM	ammonium	formate	in	25%	CAN	for	30	minutes.		
Samples	were	concentrated	again	in	a	vacuum	concentrator	prior	to	resuspension	in	.1%	formic	acid	
prior	to	mass	spectrometric	analysis.	Fractions	were	separated	on	an	inline	10cmx	75	µm	I.D.	reversed-
phase	column	packed	with	5	µm	C18	material	with	300	Å	pore	size	using	an	180-minute	gradient	of	3-
32%	acetonitrile	in	0.1%	formic	acid.		The	inline	mass	spectrometric	analysis	was	performed	on	an	
Orbitrap	XL	(Thermo).		Survey	scans	used	a	resolving	power	of	60,000,	and	the	top	ten	abundant	peaks	
were	selected	for	MS/MS	fragmentation	and	analysis.		An	exclusion	list	of	100	members,	with	early	
expiration	after	three	readings	and	monoisotopic	precursor	selection	(MIPS)	were	employed.	
2.5 Statistical, Pathway, and Upstream Regulator Analysis 
High	resolution	mass	spectrometric	data	were	analyzed	on	the	MaxQuant	processing	suite,	version	
1.4.1.2.		Spectra	were	identified	using	the	MaxQuant	built-in	peptide	identification	algorithm,	
Andromeda,	after	recalibration	to	sub	1ppm	accuracy	levels,	and	compared	against	the	UniProt	
reference	dataset	for	Mus	musculus	(45,182	proteins).		Trypsin	was	specified	as	the	digestion	protease	
with	the	possibility	of	2	missed	cleavages.		Intensities	for	all	peptides	were	assigned	by	MaxQuant	using	
full	can	mass	spectra,	and	ratios	between	heavy	and	light	SILAC	partners	were	calculated.		Identifications	
were	assigned	using	a	target/decoy	strategy	employing	reversed	false	positives	and	a	threshold	of	false	
discovery	rate	of	1%	for	peptides	and	proteins.		Ratios	were	normalized	assuming	an	average	ratio	of	
one	across	all	peptides.		The	median	value	of	all	protein	expression	ratios	was	calculated	and	analyzed	
using	the	Perseus	processing	suite.		Significance	was	established	at	a	p-value	of	less	than	0.05	using	the	
outlier	test	in	Perseus.		The	BV2	and	primary	microglia	proteomes	do	not	completely	overlap	and	thus	a	
heavy-light	pair	was	not	available	for	every	protein.		Proteins	for	which	no	heavy	chain	was	present	
were	added	to	the	analysis	as	label	free.		Proteins	that	were	identified	as	significant	were	entered	into	
Ingenuity	Pathway	Analysis	suite	to	determine	localization,	molecular	function,	and	protein	interaction	
pathways.	Upstream	Regulator	analysis	identifies	upstream	transcriptional	regulators	that	can	explain	
the	observed	gene	expression	changes	in	a	user’s	data	set.		For	each	potential	regular	two	statistical	
measures	are	taken,	an	overlap	p-value	and	activation	z-score.		The	p-value	calculates	the	overlap	
between	a	known	regulator	and	dataset	targets	of	that	gene	or	protein	while	the	z-score	infers	likely	
activation	states	based	on	a	comparison	model.		
	 	
	
	
	
	
	
Chapter	3		
NT-020	Treatment	Reduces	Inflammation	and	Augments	NRF2	and	Wnt	Signaling	in	Aged	Rats		
3.1 Abstract  
Aging	is	associated	with	a	decline	in	stem	cell	proliferation	that	is	thought	to	be	a	result	of	dysregulated	
signaling	in	the	neurogenic	niche.	This	results	in	a	diminished	and	less	efficient	pool	of	progenitors.	The	
Wnt	pathway	plays	a	key	role	in	the	proliferation	and	differentiation	of	progenitor	cells.	Recent	
publications	suggest	the	age-related	decline	in	the	function	of	Wnt	as	a	contributor	to	the	age-
dependent	decline	in	neural	progenitors.		Similarly,	the	aged	neurogenic	niche	is	characterized	by	higher	
levels	of	inflammatory	cytokines.		This	increased	inflammation	increases	oxidative	stress	on	the	cells	in	
the	niche	and	contributes	to	their	declining	function.	NT-020,	a	proprietary	blend	of	polyphenols	can	
improve	cognitive	function	and	increase	proliferation	of	neural	progenitors	in	aged	rats.		
Purpose	and	Methods	
In	this	study,	we	examined	the	neurogenic	niche	in	the	dentate	gyrus	subgranular	zone	(SGZ)	and	the	
subventricular	zone	(SVZ)	of	young	and	aged	rats	to	determine	if	dietary	supplementation	with	NT-020	
could	regulate	oxidative	stress	response	pathways	in	neurons,	astrocytes,	and	microglia.		Further,	we	
examined	NT-020's	ability	to	modulate	Wnt	signaling	in	the	aged	neurogenic	niche.		To	accomplish	this	
we	utilized	84	gene	PCR	arrays	and	immunohistochemistry.			
Results	
We	observed	an	increase	in	nuclear	localization	of	immunopositive	labeling	of	β-catenin,	HO-1,	and	
NRF2	in	all	subsets	of	cell	types	in	both	young	and	aged	rats	in	the	SGZ	following	NT-020	treatment.	In	
NeuN	positive	cells	there	was	a	basal	increase	in	nuclear	β-catenin	in	the	aged	rats,		that	was	not	
observed	in	DCX	labeled	cells,	microglia	or	astrocytes.	RT-PCR	analysis	of	isolated	hippocampal	tissue	
revealed	that	a	significant	percent	of	genes	involved	with	inflammation	are	affected	by	treatment	with	
NT-020.		In	addition,	several	genes	that	regulate	Wnt	activity	were	affected	by	supplementation.		
Conclusions	
The	results	suggest	that	NT-020	activates	oxidative	stress	response	pathways	and	supports	pro-
neurogenic	gene	expression	in	the	hippocampus.	This	may	represent	the	mechanism	by	which	the	NT-
020	formula	enhances	performance	in	learning	and	memory	tasks	in	aged	mice.	(Conflict	of	Interest,	PCB	
is	co-founder	of	Natura	Therapeutics,	Inc.	and	on	the	scientific	advisory	board	of	Nutrex	Hawaii).	
Keywords:	NT020;	b-Catenin;	Wnt	pathway;	Dentate	gyrus	subgranular	zone;	Subventricular	zone;	
Polyphenols;	Neuroinflammation	
3.2 Background 
As	the	world’s	aging	population	increases,	diseases	that	disproportionately	affect	the	elderly	will	
take	center	stage	in	biomedical	research.		In	addition	to	increasing	disease	risk,	aging	can	have	
deleterious	effects	on	neural	plasticity.		Impairments	in	long-term	potentiation	(LTP),	declines	in	
neurogenesis,	and	synapse	dysfunction	are	observed	in	the	aged	hippocampus39,41,169,170.	Interestingly	
most	of	these	age-dependent	changes	overlap	with	known	effects	of	pro-inflammatory	cytokine	
expression	(see	reviews	44,116).		Neuroinflammation	is	a	central	component	of	the	aging	milieu	and	
contributes	to	the	progression	of	a	number	of	degenerative	diseases,	see	review	171.	Polyphenolic	
compounds	have	shown	promise	in	addressing	several	aspects	of	aging	including	synaptic	dysfunction,	
decreased	neurogenesis,	and	inflammation	56,172,173.		Here	we	demonstrate	that	a	proprietary	blend	of	
polyphenolic	compounds	attenuates	inflammatory	cytokine	expression	and	enhances	pro-neurogenic	
signaling	in	the	hippocampus.	
The	hippocampus	is	unique	in	its	anatomy	as	it	is	one	of	only	two	areas	in	the	adult	brain	with	
an	extensive	stem	cell	niche174.		The	role	of	adult	neurogenesis	in	the	formation	of	new	memories	and	
enhancement	of	learning	has	been	extensively	studied	over	the	last	decade	41,45,175.		One	of	the	major	
regulators	of	adult	neurogenesis	is	the	Wnt/b-Catenin	pathway	176.		Proper	Wnt	signaling	is	crucial	for	
progenitor	proliferation,	differentiation,	and	integration	into	the	granule	layer	see	review	177-179.	
Pathological	alterations	in	Wnt	signaling	can	result	in	impairments	of	neurogenesis	and	behavioral	
deficits	152,179.		In	addition	Wnt	ligands	are	known	to	decrease	in	the	aged	hippocampus,	replacement	of	
which	is	sufficient	to	rescue	proliferation	of	neural	progenitors	in	mouse	models	179,180.		While	it	has	
been	demonstrated	that	polyphenols	like	EGCG	are	capable	of	enhancing	neurogenesis	in-vivo	no	
mechanism	for	this	action	has	yet	been	proposed.		Here,	we	investigate	the	interaction	between	
polyphenolic	compounds	and	the	Wnt/β-Catenin	pathway	as	a	possible	mechanism	by	which	
neurogenesis	is	enhanced	in	these	models.	
The	aged	hippocampus	contains	an	increased	number	of	activated	astrocytes	and	microglia,	as	
well	as	increased	levels	of	pro-inflammatory	cytokines	such	as	TNF-α	and	IL-1β171.	High	levels	of	TNF-α	
and	IL-1β	have	deleterious	effects	on	neurogenesis,	LTP,	and	synaptic	formation	171.		Genomic	and	
proteomic	profiles	of	aged	immune	cells	from	the	brain	have	yet	to	reveal	a	definitive	cause	for	these	
changes,	but	several	studies	suggest	that	oxidative	stress	caused	by	mitochondrial	dysfunction	may	be	a	
primary	contributor	181,182.		Polyphenols	have	been	shown	to	have	a	wide	range	of	neuroprotective	
effects	and	may	exert	their	action	through	modulation	of	the	immune	cells	adaptive	stress	response	
system	56,183.		The	Nuclear	factor	erythroid	2-related	factor	2	antioxidant	response	element		(Nrf2-ARE)	
pathway	is	involved	in	the	cellular	response	to	oxidative	stress	and	leads	to	the	transcription	of	several	
anti-oxidant	genes27.		Loss	of	Nrf2	increases	microglial	activation	and	leads	to	a	primed	phenotype	
similar	to	that	observed	with	aging	124,184.		In	addition,	overexpression	of	Nrf2	is	sufficient	to	attenuate	
NF-kB	signaling	and	reduce	inflammatory	responses185.		Up-regulation	of	Nrf2-ARE	may	be	a	central	
mechanism	by	which	polyphenols	attenuate	inflammation	56.			
In	this	manuscript,	we	utilized	PCR	arrays	and	the	bioinformatics	program	Ingenuity	Pathway	
Analysis	(IPA)	to	study	the	age-dependent	changes	in	the	Wnt	signaling	pathway	and	expression	of	
cytokines	in	the	hippocampus.		We	show	here	that	treatment	of	aged	mice	with	the	NT-020	formula	
decreases	expression	of	inflammatory	cytokines,	increases	expression	of	anti-inflammatory	cytokines	
and	trophic	factors,	and	decreases	several	antagonists	of	Wnt	signaling.		We	conclude	that	dietary	
supplementation	with	this	formula	is	sufficient	to	attenuate	the	neuroinflammatory	component	of	
aging.	
 3.3 Materials and Methods 
Animals	and	Procedures	
Male	Fischer	344	rats	either	young	3	months	or	20	months	of	age	were	randomly	segregated	
into	two	groups,	one	fed	an	NIH31	control	diet	and	the	experimental	group	was	fed	a	modified	diet	
which	included	the	NT-020	formulation	at	135mg/kg	for	30	days.		On	Day	30	rats	were	anesthetized	
deeply	with	isoflurane	gas	before	perfusion.	All	rats	were	divided	into	two	groups.	One	group	was	
perfused	intracardially	with	0.1M	PBS,	sacrificed,	the	hippocampus	was	removed	and	used	for	RNA	
isolation.	Another	group	was	perfused	intracardially	with	4%	paraformaldehyde	in	0.1M	sodium	
phosphate	buffer,	sacrificed,	the	brain	was	removed	and	used	for	immunohistochemistry.		All	
procedures	involving	animals	were	approved	by	the	IACUC	committee	submission	#	4389.	
	
Real	Time	RT-PCR	 	 	
Tissues	were	removed	and	microdissected	to	isolate	the	hippocampus.		Samples	were	snap	frozen	in	
liquid	nitrogen	and	stored	at	-80	degrees	C	until	homogenization.	Total	RNA	was	isolated	from	tissue	of	
adult	rat	hippocampus	using	RNeasy	mini	kit	(Qiagen,	Valencia,	CA,	USA).		Quantitative	RT-PCR	was	
performed	using	DNA	Engine	Opticon	2©	(Bio-rad	Hercules,	CA)		withMulti-stage	program	parameters	
as	follows:	10	min	at	95C,	40	cycles	of	15	s	at	95C	and	1	min	at	60C.		Samples	were	tested	in	triplicate,	
and	the	samples	obtained	from	three	to	five	independent	tissues	were	used	for	the	analysis	of	relative	
gene	expression	using	the	2−ΔΔCT	method.		The	following	PCR	arrays	were	utilized	for	this	study.		
PI3K/AKT	pathway	PARN-058Z,	WNT	signaling	targets	array	PARN-243Z,	Cytokine	and	Chemokine	array	
PARN-150Z	(Qiagen,	Valencia,	CA).		These	arrays	contain	primers	corresponding	to	84	genes	related	to	
the	individual	pathways,	five	housekeeping	genes	for	normalization,	and	positive	and	negative	controls	
for	the	PCR	reaction.		Genes	were	considered	to	be	differentially	expressed	if	their	expression	differed	
by	at	least	twofold	between	the	young	and	old	or	old	and	old	supplemented	groups,	and	that	difference	
was	statistically	significant	across	replicates	p<.05.	
	
Immunohistochemistry	and	analysis	
Immunohistochemistry	was	used	to	identify	nuclear	labeling	of	Nrf2	or	b-catenin	in	either	
neurons	(NeuN),	microglia	(IBA-1),	astrocytes	(GFAP)	or	neuronal	progenitors	(Doublecortin,	DCX)	
observed	in	young	and	aged	F344	rat	brain.	The	primary	antibodies	(1:500)	were	polyclonal	antibodies	
raised	in	rabbit	against	NeuN,	GFAP,	DCX	(Abcam)	IBA-1	(Waco)	and	monoclonal	antibodies	raised	in	
mouse	against	beta-catenin,	Nrf2	or	HO-1	(Abcam)	with	blocking	buffer(TritonX-100(0.02%),	normal	
goat	serum(4%)).	The	secondary	antiserum	(1:500)	was	Alexa488	anti-mouse,	Alexa594	anti-rabbit	IgG	
with	blocking	buffer.	To	determine	the	nuclear	co-labeled	cells,	each	field	is	550	㎛	X	550	㎛	in	the	area.			
Total	numbers	of	NeuN,	DCX,	GFAP	or	IBA-1	cells	were	counted	per	section	and	co-labeling	of	Nrf2	or	b-
catenin	with	DAPI	to	indicate	nuclear	co-labeling	cells	were	counted	from	five	different	sections	from	
each	of	six	animals.		Regions	analyzed	were	the	subgranular	zone	of	the	dentate	gyrus	of	the	
hippocampus	and	the	subventricular	zone.		The	nuclear	co-labeling	with	DAPI	was	confirmed	using	
confocal	imaging	with	2	µm	Z-steps	using	an	FV1000	MPE	confocal	microscope.	 	
ELISA	
The	protein	concentration	of	TNF-α	and	IL-1β	were	measured	in	tissue	lysates	from	
hippocampus	and	cortex	using	enzyme-linked	immunosorbent	assay	(ELISA)	from	Raybiotech	protein	
assay.		About	100µl	of	100	µg	sample	concentration	was	added	to	appropriate	wells	and	incubated	
overnight	at	4°C	with	gentle	shaking.		The	following	day,	the	solution	was	discarded	and	the	plates	were	
washed	4X	with	1X	wash	solution	(Raybiotech).		Plates	were	incubated	for	1	hour	at	room	temperature	
with	detection	antibody	and	washed	4X.		100µl	of	HRP	streptavidin	solution	was	added	to	each	well,	and	
then	incubated	for	45	mins	at	room	temperature	and	washed	4X.		100ul	of	TMB	(Raybiotech)	was	added	
to	each	well	and	incubated	for	30mins	at	room	temp	in	the	dark.		About	50µl	of	stop	solution	
(Raybiotech)	was	added.		Absorbance	was	measured	at	450	nm	immediately.			
	
3.4 Results and Discussion 
3.4.1	The	aged	hippocampus	is	a	pro-inflammatory	environment.	
We	measured	the	expression	of	84	cytokine	and	chemokine	genes	in	the	hippocampus	of	young	
and	old	(3-5	month	and	22-25	month	respectively)	male	rats	using	the	RT-PCR	cytokine	array	from	
Qiagen	PARN-150Z.		The	aged	samples	exhibited	increased	expression	of	inflammatory	genes	TNF	and	
IL-1β	(Table	1).		IL24	is	a	modulator	of	immune	response	associated	with	the	anti-inflammatory	
alternative	activations	state	of	microglia.		It	was	decreased	3	fold	in	our	data	set	(table	1)	115.	These	
results	support	previous	studies	that	reported	high	levels	of	cytokine	and	chemokine	expression	in	the	
serum	of	aged	animals.		These	results	provide	a	picture	of	the	differential	expression	of	cytokines	and	
chemokine’s	in	the	aged	hippocampus.			
	
Table	1:	Expression	of	cytokines	and	chemokine's	in	Aged	Brain	
	
Gene Symbol Gene Name P-Value 
Fold 
Change Function 
Ccl19 Chemokine ligand 19 0.03 1.868 Basal Leukocyte Migration 
Ccl2 Chemokine ligand 2 0.042 1.829 T Lymphocytes/Monocytes 
Ccl3 Chemokine ligand 3 0.003 3.304 Monocytes/ Macrophages 
Ccl4 Chemokine ligand 4 0.03 5.936 
Natural Killer 
Cells/monocytes 
Ccl5 Chemokine ligand 5 0.001 16.009 T-Cells/eosinophils 
Cxcl10 Chemokine ligand 10 0.011 4.271 Multiple 
Cxcl11 Chemokine ligand 11 0.001 3.302 T-cells 
Xcl1 Chemokine ligand 1 0.026 2.331 T-cells 
Il16 interleukin 16 0.012 -1.951 CD4+ T cells 
Tnf tumor necrosis factor 0.029 1.494 Pro-inflammatory 
Table	1	(Continued)	
Il1a interleukin 1, alpha 0.009 2.458 Pro-inflammatory 
Il1b interleukin 1, beta 0.006 4.074 Pro-inflammatory 
Il15 interleukin 15 0.009 1.669 Pro-inflammatory 
Ltb lymphotoxin beta  0.043 1.583 Pro-inflammatory 
Il24 interleukin 24 0.001 -2.925 Anti-Inflammatory 
Il1rn 
Interleukin 1, receptor 
antagonist 0.001 5.644 Anti-Inflammatory 
	
	
	
3.4.2	NT-020	increases	expression	of	anti-inflammatory	cytokines		
In	a	previous	study	of	NT-020,	aged	rats	fed	an	NT	020	diet	for	three	weeks	had	significantly	lower	
numbers	of	OX-6	(MHC	II)	positive	microglia	186.Present	results	confirm	that	this	decreased	number	of	
activated	microglia	is	paralleled	by	a	decrease	in	cytokine	and	chemokine	expression	(Table	2).		We	
again	analyzed	the	expression	of	84	cytokines	and	chemokine’s	in	the	hippocampus	of	aged	rats	fed	
either	a	control	NIH	diet	or	an	NT-020	diet.	IL24,	IL4,	and	IL10	are	cytokines	with	anti-inflammatory	or	
immune	modulating	effects	whose	expression	was	increased	in	the	NT020	diet	group	(table	2).	Further,	
expression	of	CX3CL1	(fractalkine),	LIF	and	GDNF	was	also	observed	(table	2,	4).		Expression	of	these	
markers	is	indicative	of	microglia	in	an	M2	or	alternative	activation	state	which	supports	tissue	repair	
and	stem	cell	proliferation	105,115.		Expression	of	the	pro-inflammatory	cytokine	genes	IL-1a	and	IL18	
(table	3.2)	was	decreased	as	was	an	expression	of	chemokine’s	CCL19	and	CCL2	known	to	be	involved	in	
trafficking	of	T	cells	to	the	CNS	143.		We	also	performed	an	ELISA	assay	to	measure	levels	of	both	TNF-α	
and	IL-1β.		Protein	levels	were	significantly	increased	in	the	old	hippocampus	(figure	1)	NT-020	
treatment	decreased	protein	levels	of	both	TNF-α	and	IL-1β	in	22-month-old	rats(figure	1).		These	
results	suggest	that	dietary	supplementation	with	NT-020	increases	expression	of	immune-modulatory	
molecules	within	the	hippocampus.		Interestingly	as	in	a	previous	study	186		with	NT-020,	this	was	also	
accompanied	by	an	improvement	in	performance	on	a	spatial	learning	task,	in	this	case,	the	radial	arm	
water	maze	in	the	aged	rats	(Figure	2),	but	not	in	young	rats	(figure	3).	
		
Figure	1:	TNF-α	and	IL-1β	protein	expression	in	the	CNS	as	measured	by	ELISA	assay.		Asterisks	indicate	
significant	differences	between	the	groups.		In	(A)	Aged	rats	fed	with	NT-020	supplemented	diet	show	a	20%	
reduction	of	TNF-α	protein	expression	in	the	hippocampus	in	compare	with	aged	rat	fed	with	control	diet.(B)	in	the	
aged	rat	fed	with	NT-020	diet	,	the	IL1-β		protein	expression	in	the	hippocampus,		decreased	approximately	25%	in	
compared	with	aged	rat	fed	with	control	diet.		There	is	an	overall	age-related	increase	of	TNF-α	and	IL-1β	
expression	in	the	hippocampus	with	age.		(Two-way	analysis	of	variance	[ANOVA]	in	figure	2A,	F=	19.91,	degrees	of	
freedom	[df	]=	1,	followed	by	Bonferonni	post	hoc	values	[***]	p<0.001.		In	figure	2B,	F=	24.09,	[df]=1,	followed	by	
Bonferonni	post	hoc	values	[*]	p<0.05.		In	figure	2C,	F=	5.045,	[df]=1,	followed	by	followed	by	Bonferonni	post	hoc	
values	[*]	p<0.05.	
	
	
In	an	attempt	to	identify	possible	regulators	upstream	of	our	target	molecules,	we	performed	upstream	
and	downstream	analysis	in	the	bioinformatics	program	Ingenuity	Pathway	Analysis	(figure	4).		The	
upstream	analysis	predicts	that	inhibition	of	RELA	the	p65	subunit	of	NFkB	could	explain	the	treatment	
effect	which	is	consistent	with	previous	reports	that	EGCG	was	capable	of	inhibiting	NF-kBin	T	cells	in	a	
model	of	MS187.		In	addition,	there	is	a	predicted	increase	in	activity	of	corticosterone	(CORT)	(figure	
4B).	Low	levels	and	short	durations	of	corticosteroids	are	known	to	have	anti-inflammatory	effects	
however	here	it	is	unlikely	that	supplementation	triggered	the	release	of	these	compounds.		Instead,	we	
propose	that	in	the	primed	state	of	the	aged	hippocampus	there	may	be	a	blunted	response	to	
corticosterone	signaling	which	is	restored	after	supplementation.	
	
Figure	2:	Performance	on	the	radial	arm	water	maze	of	aged	(21	month	old)	rats	across	days.			A	
learning	criterion	was	set	to	1	error	as	shown	with	the	dashed	line.		As	can	be	observed	aged	rats	reach	criterion	
by	Day	4.	The	performance	of	old	rats	on	trials	1	and	2	of	the	second	day	of	training	was	improved	by	NT-020	
treatment.				There	was	also	improved	performance	during	reversal	training	of	radial	arm	water	maze	(unpaired	t-
test	aged	rats	control	vs.	aged	rats	treatment	trial	1	of	day	2p=	0.0413,	trail	2	of	day	2	p=0.0399,	trial	3	of	RT	
p=0.0317).	
	
	
	Figure	3	Performance	on	the	radial	arm	water	maze	of	young	(4-month-old)	rats	across	days.	A	
learning	criterion	was	set	to	1	error	as	shown	with	the	dashed	line.		As	can	be	observed	young	rats	reach	criterion	
by	day	3	of	training.Treatment	of	young	rats	with	NT-020	did	not	alter	performance	during	training,	although	there	
was	a	difference	during	the	probe	trial,	but	not	the	reversal	training.		(Two-way	ANOVA	with	repeated	measures	
revealed	aging	group	differences)	
 
 
 
	 	
Table	2:	Expression	of	Proinflammatory	cytokines	attenuated	by	the	N020	diet.	
	
Gene 
Symbol 
Gene Name P-Value Fold 
Change 
Process 
Lif Leukemia inhibitory factor 0.018 2.881 Neurotrophin 
Gpi Glucose phosphate isomerase 0.005 1.569 Neurotrophin 
Cx3cl1 Chemokine (C-X3-C motif) ligand 
1 
0.011 1.602 Anti-Inflammatory 
Cxcl12 Chemokine (C-X-C motif) ligand 
12  
0.034 1.436 Anti-Inflammatory 
Il10 Interleukin 10 0.049 1.695 Anti-Inflammatory 
Il1rn Interleukin 1 receptor antagonist 0.009 -1.682 Anti-Inflammatory 
Il18 Interleukin 18 0.033 -1.607 Pro-inflammatory 
Il1a Interleukin 1 alpha 0.011 -2.034 Pro-inflammatory 
Il24 Interleukin 24 0.025 1.699 Anti-Inflammatory 
Ccl19 chemokine (C-C motif) ligand 19 0.047 -1.506 Chemotaxis 
Ccl2 chemokine (C-C motif) ligand 2 0.047 -1.988 Chemotaxis 
Il16 Interleukin 16 0.037 1.798 Chemotaxis 
	
A	recent	study	examined	the	potential	role	of	excess	glucocorticoids	in	leading	to	brain	aging	and	AD,	a	
novel	finding	was	observed	when	comparing	the	glucocorticoid	transcriptome	with	the	aging	
transcriptome.		Although	the	prevailing	hypothesis	relates	to	over-activation	of	corticosteroids	with	age	
these	authors	observed	that	many	genes	including	the	inflammatory	genes	that	are	up-regulated	with	
age	are	downregulated	by	cortisol	treatments	suggesting	a	down-regulation	of	glucocorticoid	responses	
with	age	in	some	cells	that	could	be	responsible	for	the	increased	inflammatory	response	with	age	188.		
Further	studies	are	needed	to	determine	if	these	upstream	regulators	are	altered	in	the	aged	rats	with	
NT-020	treatment.		Downstream	analysis	of	bio-functions	gives	an	interpretation	of	the	gene	expression	
data.		This	analysis	is	consistent	with	a	decrease	in	both	syntheses	of	nitric	oxide	a	major	source	of	
oxidative	stress	in	the	CNS,	the	influx	of	granulocytes,	and	the	TH1	immune	response	(Figure	4C).		
Notably,	the	genes	at	the	center	of	these	predictions	include	the	anti-inflammatory	genes	IL4	and	IL10.			
Taking	a	systematic	view	of	the	data	has	demonstrated	that	the	anti-inflammatory	effects	of	dietary	
supplementation	are	broad	and	involve	modulating	the	activity	of	multiple	cell	types	in	the	niche.			
	
	3.4.3	NT	020	increases	nuclear	expression	of	Nrf2	in	the	dentate	gyrus	of	the	hippocampus.	
Polyphenolic	compounds	can	activate	adaptive	stress	response	pathways	in	the	cell,	most	
notably	NRF2-ARE	56.		Because	activation	of	Nrf2	is	capable	of	attenuating	the	inflammatory	response	
we	investigated	NT-020’s	ability	to	drive	Nrf2	activation	in-vivo185.		Immunohistochemistry	was	used	to	
examine	cellular	localization	of	Nrf-2	and	one	of	the	enzymes	regulated	by	Nrf-2,	heme-oxygenase	1	in	
the	dentate	gyrus	of	the	hippocampus.		Doublecortin	(DCX),	IBA-1,	NeuN,	and	GFAP	were	used	to	label	
immature	neurons,	microglia,	neurons,	and	astrocytes	respectively.		Using	confocal	microscopy	we	
randomly	counted	100	cells	per	animal	and	then	determined	if	the	expression	of	Nrf-2	was	observed	in	
the	nucleus	(Figure	5).			
The	percent	of	cells	with	nuclear	co-localization	of	Nrf-2	and	HO-1	was	significantly	increased	in	
all	four	cell	types	in	the	rats	that	received	the	NT-020	diet	(Figure	6).		This	increase	occurred	with	
treatment	in	both	young	and	old	rats	suggesting	that	these	effects	are	independent	of	basal	
inflammation	status.		This	supports	that	at	least	some	of	the	polyphenolic	activity	in-vivo	comes	from	an	
activation	of	antioxidant	response	element	pathways	across	most	cell	types	in	the	CNS.		Interestingly,	
the	role	of	Nrf-2	in	microglial	priming	has	become	delineated	in	many	studies	including	a	recent	study	
suggesting	that	Nrf2	is	important	for	phagocytosis	189.		In	addition,	Nrf-2	is	a	regulator	of	CX3CL1	actions,	
one	of	the	chemokines	upregulated	by	NT-020	treatment	reported	in	Table	2190.			
	
	Figure	4:	A.	Downstream	analysis	of	Wnt-related	gene	expression	from	aged	animals	predicts	a	
decrease	in	cell	viability	and	transcription	of	RNA.			B.	Analysis	of	upstream	regulators	of	cytokine	expression	in	
animals	supplemented	with	NT-020	predicts	a	decrease	in	the	activity	of	the	p65	subunit	of	NF-ΚB	(RELA)	and	an	increase	in	
corticosterone	activity	as	determined	by	the	concordant	activity	of	their	identified	downstream	targets.		C.	Downstream	
analysis	of	gene	expression	predicts	a	decrease	in	NO	synthesis,	TH1	immune	response,	and	the	influx	of	granulocytes	as	a	
result	of	the	modulation	in	indicated	gene	activity.	D.		Upstream	analysis	of	the	Wnt	pathway	predicts	inhibited	the	activity	of	
Sonic	Hedgehog	(SHH)	and	EGF	receptor.	
	
	Figure	5:			Confocal	microscopy	was	used	to	examine	the	nuclear	localization	of	Nrf2	and	β-catenin.			
Cellular	markers	were	used	to	determine	specific	localization	in	newborn	neurons	with	doublecortin	(DCX),	astrocytes	with	
GFAP,	mature	neurons	with	NeuN	and	microglia	with	IBA-1.			Here	are	shown	a	few	examples	of	the	confocal	images	
demonstrating	nuclear	(DAPI,	blue)	co-localization	of	β-catenin	or	Nrf-2	(green)	in	DCX	or	IBA-1	(red)	positive	cells	in	the	NT-020	
treated	aged	rats.			Z-stacks	(1	micron)	were	taken	and	rotated	in	2	dimensions	as	shown	in	the	side	panels	of	the	figures	on	the	
left	of	each	subpanel	for	control	and	NT-020	treated	rats.			Higher	power	images	are	inserted	to	the	right	of	each	image	
focusing	on	the	cell	at	the	center	of	the	Z-stack	rotations.		Only	cells	with	clear	co-labeling	from	all	3	views	were	counted.		
	
	
Figure	6.			Bar	graph	summarizing	the	percent	nuclear	localization	of	Nrf2,	HO-1	and	b-catenin.				For	
each	condition	at	least	100	cells	were	counted	except	for	the	aged	DCX	condition	where	this	was	not	possible	due	to	low	cell	
counts.				As	can	be	seen,	NT-020	treatment	increases	the	percent	of	cells	with	nuclear	expression	of	all	three	proteins	in	all	four	
cell	types	independent	of	the	age	of	the	rats	(One	way	ANOVA	followed	by	Tukey’s	posthoc	analysis		***	p<0.001	for	treatment	
versus	age-matched	control	condition.		DCX/b-catenin	F=20.63,	df	3;	DCX/Nrf2	F=	12.69,	df	3;	DCX/HO-1	F=26.87	df=3;		GFAP/b-
catenin	F=	86.53,	df=3;	GFAP/Nrf2	F=	65.37,	df=3;	GFAP/HO-1	F	=	107.9,	df	=	3;	NeuN/b-catenin	F=	77.1,	df=3;	NeuN/Nrf2	F=	
190.7,	df=3;	NeuN/HO-1	F=	165.3,	df=3;	IBA-1/b-catenin	F=	144.1,	df=3;	IBA-1/Nrf2	F=	86.3,	df=3;	IBA-1/HO-1	F	=	84.16,	df=3).			
Baseline	nuclear	localization	of	b-	catenin	was	observed	in	mature	neurons	and	microglia	in	aged	rats	compared	with	young	rats	
p<0.05	(Tukey’s	multiple	comparison	tests).			Basal	nuclear	localization	of	HO-1	was	only	increased	in	the	astrocytes	in	the	aged	
rats	p<0.05	(Tukey’s	multiple	comparison	tests).	
	
	
	
	
3.4.4	NT-020	increases	nuclear	localization	of	b	catenin	in	the	dentate	gyrus	of	aged	animals	
Wnt	ligand	binding	to	its	receptor	triggers	an	accumulation	of	intracellular	b-catenin	that	correlates	with	
overall	Wnt	activity	191.	To	gain	better	insight	into	the	activity	level	of	the	Wnt	pathway	we	stained	
hippocampus	sections	as	above	for	Nrf2	for	nuclear	co-localization	with	b-catenin.		The	aged	group	had	
reduced	percent	of	DCX	positive	cells	with	nuclear	co-labeled	b-catenin	although	it	only	approached	
significance	(Figure	6).		However,	compared	to	control,	rats	on	the	NT-020	diet	have	a	higher	percent	of	
nuclear	co-localization	of	b-catenin	in	all	cell	types.		This	supports	the	hypothesis	that	the	NT-020	diet	
increases	overall	activity	of	the	Wnt	pathway	in	aged	animals.		Similar	results	are	observed	in	the	SVZ	
(Figure	7).		To	examine	this	further	we	analyzed	gene	expression	of	Wnt	target	genes.		
3.4.5		NT-020	increases	expression	of	Wnt	Target	Genes	
Analysis	of	Wnt	signaling	revealed	significant	changes	in	genes	responsible	for	regulating	both	
the	cell	cycle	and	cell	fate	decisions	(Table	3).		The	causes	of	the	age-related	decline	in	neurogenesis	in	
the	hippocampus	are	still	not	fully	clear	but	several	studies	examining	Wnt	ligands	suggest	the	
decreased	signaling	particularly	the	decrease	in	the	Wnt3a	ligand	is	at	least	partly	responsible	for	the	
decline	179.		Wnt	target	genes	associated	with	cell	cycle:	Cyclin	D1,	C-Myc,	and	AHR	were	decreased	by	
1.6,	2.1,	and	2.12	fold	respectively	(table	3).	Growth	factors	GDNF	and	IGF2	expression	were	reduced	by	
2.7	and	3.6	fold	respectively.				Extracellular	antagonists	block	ligand	access	to	the	FZD	receptors	
preventing	signal	transduction.	We	observed	increases	in	Wnt	signaling	antagonists	SFRP2	and	TLE1	
which	were	increased	by	1.51	and	1.58	fold	respectively	(table	3).	
	
Figure	7	Confocal	microscope	was	used	to	examine	the	nuclear	localization	of	Nrf2,	HO-1,	and	β-
catenin.			Four	cellular	markers	were	used	to	determine	specific	localization	in	newborn	neurons	with	doublecortin	(DCX),	
astrocytes	with	GFAP,	mature	neurons	with	NeuN	and	microglia	with	IBA-1.For	each	condition	at	least	100	cells	were	counted	
except	for	the	aged	DCX	condition	where	this	was	not	possible	due	to	low	cell	counts.				As	can	be	seen,	NT-020	treatment	
increased	nuclear	expression	of	all	three	proteins	in	all	four	cell	types	independent	of	the	age	of	the	rats.		One	way	ANOVA	
followed	by	Tukey’s	posthoc	analysis		***	p<0.001	for	treatment	versus	age-matched	control	condition	DCX-Nrf2	F=26.96,DF=3	
;	DCX-HO1	F=10.70,DF=3;	DCX-BetaCa	F=64.89,	df=3;	GFAP-Beta-CA	F=89.82,	DF=3;	GFAP-Nrf-2	F=125.9,DF=3;	GFAP-HO1	
F=87.81,DF=3;	NeuN-Nrf2	F=72.16,DF=3;NeuN-BetaCa	F=66.13,DF=3;	NeuN-HO1	F=	77.43,DF=3;	IBA1-BetaCa	
F=48.96,DF=3;IBA-1Nrf2	F=28.64,DF=3;	IBA1-HO1	F=34.78,	DF=3).	
	
	
Another	DKK1	was	also	increased	but	only	approached	significance.		In	addition	to	extracellular	
antagonists,	several	co-repressors	exist	in	the	nucleus	to	antagonize	TCF/LEF	signaling.		TLE1	or	Groucho	
is	one	such	repressor	that	binds	TCF	and	prevents	its	transcriptional	activity	in	the	absence	of	beta-
catenin.	These	results	suggest	that	antagonism	of	Wnt	signaling	is	a	significant	factor	affecting	Wnt	
signal	transduction	in	the	aged	brain.	Taken	together	these	alterations	paint	the	picture	of	a	cell	
environment	with	a	decrease	in	extracellular	growth	and	survival	signals	which	correlate	with	the	
observed	effects	of	aging	on	neurogenesis.					
		Table	3:	Expression	of	Wnt	targets	is	decreased	in	aged	hippocampus	
Gene 
Symbol 
Gene Name P-Value Fold 
Change 
Functional Gene Group 
Myc Myelocytomatosis oncogene 0.033 -2.180 Cell Cycle 
Gdnf Glial cell derived neurotrophic 
factor 0.038 -2.744 
Neurotrophin 
Bmp4 Bone morphogenetic protein 4 0.048 -1.566 TGF-β Signaling 
Igf2 Igf2 0.002 -3.674 Growth Factor 
Fosl1 Fos-like antigen 1 0.044 -2.110 Transcription Factors 
Sox9 SRY-box containing gene 9 0.016 -2.325 Transcription Factors 
Sfrp2 Secreted frizzled-related 
protein 2 0.042 1.517 
Wnt Signaling 
Tle1 Transducin-like enhancer of 
split 1) 0.030 1.585 
Wnt Signaling 
	
3.4.7	NT-020	increases	expression	of	pro-neurogenic	genes		
Gene	expression	from	NT-020	treated	rats	revealed	a	complex	pattern	of	gene	regulation	that	may	
represent	a	novel	mechanism	by	which	these	compounds	affect	neurogenesis	(table	4).	Growth	factors	
GDNF	and	FGF4	levels	were	increased,	both	of	which	support	proliferation	and	survival	of	young	neural	
progenitors.		An	increase	in	NANOG	supports	the	notion	that	more	pluripotent	cells	are	present	in	
treated	animals.	Paradoxically	expression	of	the	Wnt3a	gene	was	reduced	in	the	supplemented	group	
while	nuclear	co-localization	of	b	catenin	was	increased.		One	possible	explanation	is	that	restoration	of	
Wnt	signal	transduction	by	reduction	of	antagonists	SFRP2,	TLE1,	and	WISP1	triggered	a	negative	
feedback	mechanism.	Expression	of	transcription	factor	DLK1,	a	transmembrane	member	of	the	Notch	
family	was	increased	after	supplementation.		Studies	on	DLK1	indicate	that	it	promotes	neurogenesis	
through	its	modulation	of	Notch	and	BMP	pathways	192.		Overall	the	gene	expression	changes	are	
consistent	with	increased	Wnt	downstream	signaling.		We	postulate	that	this	is	a	result	of	reduced	
expression	of	negative	regulators.		These	results	put	forward	several	possible	mechanisms	by	which	NT-
020	rescues	neurogenesis	in	the	aged	niche	and	further	analysis	is	necessary	to	understand	what	role	
these	changes	play	in	attenuation	of	the	aged	phenotype.	 
Table	4:	NT	020	diet	increases	expression	of	genes	involved	in	regulating	self-renewal	
Gene 
Symbol 
Gene Name P-
Value 
Fold 
Change 
Functional Gene Group 
Gdnf Glial cell derived neurotrophic 
factor 0.020 2.231 
Neurotrophin 
Dlk1 Delta-like 1 homolog 
(Drosophila) 0.023 4.728 
Differentiation and 
Development 
Id2 Inhibitor of DNA binding 2 
0.002 -1.569 
Differentiation and 
Development 
Fgf4 Fibroblast growth factor 4 0.015 1.899 Growth Factor 
Nanog Nanog homeobox 0.016 1.809 Transcription Factors 
Sfrp2 Secreted frizzled-related protein 
2 0.001 -2.685 
Wnt Signaling 
Tle1 Transducin-like enhancer of 
split 1 (E(sp1) homolog, 
Drosophila) 0.006 -2.000 
Wnt Signaling 
Wisp1 WNT1 inducible signaling 
pathway protein 1 0.007 -2.166 
Wnt Signaling 
Wnt3a Wingless-type MMTV member 
3A 0.038 -5.209 
Wnt Signaling 
	
3.5 Conclusion 
The	impact	of	age-dependent	inflammation	in	the	CNS	is	known	to	drive	the	progression	of	the	
neurodegenerative	disease	and	contribute	to	the	decline	of	tissue	homeostasis	even	in	the	absence	of	
an	underlying	disease.		The	negative	impact	of	inflammatory	cytokines	on	processes	vital	for	cognitive	
function	has	been	well	documented	(see	review	171).		While	it	is	not	fully	understood	how	declining	
neurogenesis	directly	impairs	learning	it	has	been	shown	to	be	an	early	event	in	the	pathology	of	several	
diseases	including	Alzheimer’s	41.		This	report	describes	for	the	first	time	an	increase	in	Wnt	antagonists	
in	the	aged	hippocampus	and	their	attenuation	by	supplementation	with	NT-020.		It	is	not	clear	whether	
this	occurs	as	a	direct	result	of	the	associated	attenuation	of	inflammation	and	increase	in	Nrf2-ARE	
pathways	or	by	an	independent	mechanism.	However,	signaling	in	the	niche	rarely	occurs	unilaterally	
and	it	is	likely	that	these	compounds	act	on	supporting	cells	such	as	astrocytes	or	microglia	in	addition	
to	actions	directly	on	the	neural	progenitor	cells	themselves.		Another	finding	that	may	be	of	particular	
importance	in	the	NT-020	treatment	group	is	an	increase	in	the	anti-inflammatory	chemokine	CX3CL1	
and	a	decrease	in	chemokines	such	as	CCL19	and	CCL2	that	are	upregulated	during	periods	of	
inflammation	and	facilitate	the	invasion	of	peripheral	leukocytes	143.		While	we	did	not	directly	measure	
leukocyte	invasion	or	blood	brain	barrier	permeability	it	is	known	to	be	altered	with	age	193	and	it	would	
be	interesting	to	examine	the	effectiveness	of	NT-020	supplementation	on	these	parameters	in	disease	
models	involving	chronic	inflammation.			
It	is	clear	that	an	age-related	increase	in	microglial	priming	has	direct	actions	on	the	neurogenic	
niche.			Aged	microglia	when	co-cultured	with	neural	progenitors	reduces	stem	cell	proliferation	194.			It	
has	been	suggested	that	this	impairment	of	neurogenic	niche	function	is	driven,	at	least	in	part,	by	Nrf2	
139.		Treatments	that	increase	Nrf2	reduced	microglial	priming	and	reduced	the	effect	of	aged	microglia	
to	inhibit	neural	progenitor	proliferation	139,	interestingly	these	authors	also	suggested	that	this	was	
associated	with	increased	Wnt	signaling	139,	all	of	which	were	observed	in	this	study.		Our	findings	
demonstrate	increased	Nrf-2	translocation	to	the	nucleus	after	NT-020	treatment,	and	an	increase	in	
HO-1	one	of	the	enzymes	regulated	by	this	transcription	factor.		Nrf-2	has	been	shown	to	protect	
neurons	from	increased	oxidative	stress	during	periods	of	inflammation185,		Further,	Nrf-2	plays	a	role	in	
microglial	priming	as	the	absence	of	Nrf2	changes	microglial	phenotype	towards	that	of	increased	M1	184	
the	primed	microglial	phenotype	that	is	observed	with	normal	aging124.		Recent	evidence	linking	Nrf2-	
ARE	to	the	regulation	of	immune	cells	include	that	Nrf2-ARE	is	essential	for	promoting	phagocytosis	of	
phosphorylated	tau	by	microglia/macrophages	as	shown	by	a	reduction	in	phagocytosis	using	a	Nrf2	
decoy	189.	In	addition	increased	expression	of	Nrf-2	has	been	shown	to	attenuate	inflammation	by	
blocking	NF-kB	activity	195.		
Taken	together	our	results	demonstrate	that	NT-020	at	concentrations	attainable	through	
dietary	supplementation	effectively	target	multiple	processes	that	contribute	to	cognitive	decline	during	
aging	as	well	as	the	progression	of	neurodegenerative	disease.		
	 	
	
	
	
	
	
Chapter	4:		Proteomic	Analysis	of	Aged	Microglia:	Loss	of	Transcriptional	Control	and	Shifts	in	
Bioenergetics	in	the	Context	of	Priming.	
4.1 Introduction 
Aging	is	a	complex	phenomenon	that	profoundly	alters	the	landscape	of	our	physiology.			These	
alterations	play	a	role	in	creating	an	environment	in	which	chronic	and	degenerative	diseases	can	
progress	1.		Age	is	a	leading	risk	factor	for	a	wide	number	of	diseases	including	cancer,	dementia,	and	
neurodegenerative	diseases.			Aging	is	best	described	as	the	progressive	loss	of	integrity	leading	to	loss	
of	function	in	organ	and	tissue	systems.			The	effects	of	aging	are	significantly	pronounced	in	the	
immune	system.		In	the	peripheral	immune	system,	there	is	a	loss	of	naïve	T	cells	with	age,	which	
accompanies	a	dysregulated	cross-talk	between	T	cells	and	B	cells	in	the	lymph	nodes	93.		The	
inflammatory	response	is	a	well-orchestrated	set	of	events	that	coordinate	multiple	stages	of	cellular	
differentiation,	movement,	and	activation.		There	is	an	apparent	loss	of	this	coordination	in	aged	
animals,	culminating	in	impaired	cross-talk	between	T	cells	and	macrophages	15	196.		Aged	macrophages	
exhibit	a	loss	of	functional	plasticity	and	appear	to	be	primed	towards	a	pro-inflammatory	phenotype	
197.		In	addition,	they	have	an	altered	transcriptional	profile	in	response	to	receptor	activation,	likely	
contributing	to	their	loss	of	plasticity	196.		In	the	CNS	the	immune	landscape	differs	from	that	of	the	
periphery.		While	the	CNS	is	no	longer	believed	to	be	as	“immune	privileged”	as	it	once	was,	the	cells	
that	make	up	the	majority	of	the	immune	landscape	are	the	resident	macrophage	the	microglia.		These	
cells	are	critical	throughout	life,	including	during	development	for	proper	CNS	function.		In	addition	to	
their	roles	as	immune	cells,	they	support	synaptic	function	through	pruning,	a	necessary	process	for	
learning	consolidation	108,198.		Microglia,	are	regulators	of	neurogenesis	and	provide	vital	support	roles	to	
neurons	through	their	production	of	neurotrophins	during	periods	of	stress	or	injury	117.			
Microglia,	like	immune	cells	in	the	periphery,	undergo	dramatic	changes	with	age	199.		The	aged	CNS	is	
characterized	by	higher	levels	of	inflammatory	cytokines	and	chemokines	in	the	absence	of	insult	199.		
Aged	microglia,	have	dystrophic	morphologies	and	loss	of	dendritic	processes	that	are	vital	for	
communication	with	their	environment	and	the	maintenance	of	synapses	121.			There	is	evidence	that	
these	changes	contribute	to	the	cognitive	decline	normally	seen	with	age,	which	in	severe	cases	can	
result	in	cognitive	impairment	and	dementia	171.		There	is	also	evidence	that	this	loss	of	microglial	
function	is	a	necessary	step	for	the	development	of	neurodegenerative	disease	119.		Aged	microglia	
exhibit	exaggerated	and	prolonged	responses	to	inflammatory	stimuli	and	are	resistant	to	regulation	by	
the	anti-inflammatory	stimulus	122,200,201.		Microglia	have	been	observed	aggregating	near	amyloid	
plaques	and	stain	positively	for	amyloid	in	post-mortem	brain	tissue	44.		The	chronic	neurodegenerative	
disease	is	characterized	by	an	on-going	inflammatory	reaction	that	likely	contributes	to	the	worsening	of	
pathology	44.			
Studies	of	aged	microglia	at	the	systems	level	have	revealed	altered	transcriptional	patterns	that	further	
confirm	a	pro-inflammatory	phenotype103.		The	majority	of	studies	so	far	have	analyzed	the	
transcriptome	using	a	variety	of	tools	including	RNA	sequencing	and	DNA	microarrays,	both	with	their	
advantages	and	disadvantages.		
In	this	study,	the	effects	of	age	on	the	cellular	systems	of	microglia	was	examined	through	mass-
spectrometry-based	proteomics.		This	approach	offered	several	advantages	over	transcript	based	
methods	including	improved	accuracy	and	the	chance	to	observe	changes	in	molecules	that	occur	at	the	
multiple	levels	post-transcription.		Protein	expression	networks	in	pure	populations	of	microglia	from	
young	and	aged	mice	were	examined	using	functional	clustering	analysis	(14).		From	these	clusters,	the	
cellular	systems	contributing	to	the	underlying	changes	in	biology	came	into	focus.		Next,	proteins	were	
enriched	for	canonical	pathways	in	order	to	identify	signaling	pathways	with	the	greatest	impacts	due	to	
aging.	Upstream	regulator	analysis	was	performed	to	identify	molecules	whose	activity	had	the	potential	
to	explain	the	behavior	of	downstream	proteins	enriched	in	the	identified	pathways.		From	these	
potential	regulators,	the	mTORC2	component	protein	RICTOR	was	identified	as	a	promising	target	for	
intervention	in	the	age-dependent	dysfunction	of	microglia.		Our	proteomic	dataset	represents	the	first	
comprehensive	age-related	microglial	protein	expression	profile	and,	in	conjunction	with	bioinformatic	
analysis,	has	provided	molecular	insight	into	phenotypic	changes	that	occur	in	microglia	upon	aging	
4.2 Results and Discussion 
4.2.1	Proteomics-based	identification	of	aging-related	proteins	
Stable Isotope Labeling with Amino acids in Cell culture “SILAC”, is a metabolic labeling 
approach that allows for relative protein quantitation with fairly high accuracy.  However, this 
method typically requires proliferating cells in order for the heavy-labeled amino acids to 
integrate into the proteome.  We have adapted this method to allow for quantitative proteomic 
analysis of primary microglia in which heavy-labeled protein from the microglial BV2 cell line 
was utilized as a spike-in standard.  This approach allowed us to overcome the challenge of 
integrating heavy labeled amino acids into primary microglia isolated from adult mice in which 
incorporation efficiency is limited by post-isolation culture time.  To overcome differences in 
coverage between the BV2 proteome and primary cells (outside of the range for SILAC-based 
quantitation), we performed label-free quantitation using intensities measured for primary 
microglia.  After input of database search results into the Scaffold program, our mass 
spectrometric analysis identified 1,944 proteins in 1823 clusters without consideration of 
modifications (e.g., post-translational or SILAC) in order to establish proteome depth of 
coverage for the primary microglia. Criteria for protein identification included a threshold of <1% 
FDR at the protein and peptide level with a minimum of 2 unique peptides identified for each 
protein. When considering modifications, which includes SILAC labels for the BV2 proteome, 
2,843 proteins (57 of which are potential contaminants) in 2,713 clusters were identified. To 
determine differentially expressed proteins, we performed Student’s t-test between the young 
and aged groups.  The proteins at this significance threshold (271 total differentially expressed 
proteins, were utilized for subsequent bioinformatic analysis. No multiple testing was applied in 
order to maximize proteome depth of coverage typically necessary to enhance bioinformatic 
output. However, we have provided a separate table that filters differentially expressed proteins 
by both Welch’s t-test as well as z-score (see methods). This type of filtering approach has been 
shown to be less stringent than multiple testing correction methods (e.g., Bonferroni or 
Benjamini-Hochberg) while still maintaining adequate FDR and sensitivity 202. Several 
differentially expressed proteins (out of 156 total differentially expressed proteins) related to 
microglial function are shown in Figure 8. These include those that are known microglial 
markers (e.g., AIF1/IBA-1 and HEXB) and/or involved in immune response (e.g., H-2 class I 
histocompatibility antigen and interferon-related proteins). IBA-1 is a component of the MHC 
class III complex and is upregulated in the brain by microglia during an inflammatory response.  
Previous studies of the aged hippocampus observed a higher number of microglia expressing 
MHC molecules, including IBA-1, suggesting a pro-inflammatory state 121. The overall direction 
of fold-change-based on some of these selected proteins suggests an amplified activated state 
and/or pro-inflammatory posture of microglia isolated from old mice when compared to young 
animals. Other proteins were selected to demonstrate quantitation results for those involved in 
biological processes implicated in age-related microglial functional changes discussed later. In 
order to determine molecular pathways  
and potential regulatory mechanisms associated with age-related microglial priming, we then 
used the Ingenuity Pathway Analysis platform and DAVID GO database to analyze relationships 
between cellular pathways and systems.   
	
	
Figure 8: Age-related differential expression of selected microglial proteins.		SILAC	or	label-free	
ratios	were	determined	by	MaxQuant	and	then	normalized	to	the	young	group	for	each	individual	protein.	Error	bars	represent	
SEM	and	statistical	significance	was	determined	by	Welch’s	t-test	(p<0.05)	and	|z-score|>1.			
	
	
	
	
	
4.2.2	Altered	Functional	Processes	Identified	in	Aged	Microglia	
Functional	processes	were	identified	using	the	functional	categories	in	the	GO	database	203	that	were	
represented	by	a	statistically	higher	proportion	of	proteins	in	the	differentially	expressed	group	than	
would	be	predicted	by	chance.		To	accomplish	this	we	used	the	DAVID	platform	204.		The	functional	
annotation	clustering	tool	was	also	used	to	group	overrepresented	functional	processes	based	on		
overlap	among	populating	proteins.		Differentially	expressed	proteins	that	were	up	or	down-regulated	
were	uploaded	and	analyzed	separately.			
Table	5	contains	overrepresented	functional	processes	for	upregulated	and	downregulated	proteins	as		
well	as	a	list	of	the	proteins	involved	in	each.		To	reduce	redundancy,	Table	5	only	contains	processes	
that	are	the	most	informative	and	characteristic	of	each	cluster.	The	full	list	is	available	in	the	
supplemental	material.	
	
4.2.3	Disruptions	in	Chromatin	Remodeling	and	Transcriptional	Regulation	
When	examining	functional	categories	including	gene	ontology	functions	and	keywords,	downregulated	
proteins	were	enriched	for	functions	related	to	RNA	processing	and	chromatin	modification	(table	5).		
Terms	like	chromatin	organization,	helicase	activity,	regulation	of	transcription,	and	chromatin	
remodeling	complex,	suggest	aged	microglia	have	impairments	in	their	ability	to	appropriately	regulate	
proteins	at	the	epigenetic/transcriptional	level.		Central	to	the	maintenance	of	the	chromatin	and	
epigenetic	regulation	are	histones	proteins.	The	histone	linker	protein	Histone	H1.5	(Hist1h1b)	allows	
for	the	compaction	of	chromatin	into	higher	order	structures	and	is	downregulated	~6	fold	in	our	
dataset	table	6.		In	addition	to	the	chromosome,	structural	histones	play	a	role	in	transcriptional	
regulation	through	post-translation	modifications	like	methylation	and	acetylation	64.		Proteins	
responsible	for	these	modifications	make	up	chromatin	remodeling	complexes	of	which	NuRD	and	
SWI/SNF	are	two	examples	33.		Core	components	of	each	(CHD4,	MTA2)	and	(Smarca4,2,	ACTL6a)	are	
downregulated	in	our	dataset	table	6.		Both	complexes	are	involved	in	the	transcriptional	regulation	of	
macrophage	polarization	and	inflammatory	signaling	205.		A	prominent	feature	of	aged	microglia	is	the	
loss	of	polarization	fluidity,	or	the	ability	to	switch	from	one	activation	state	to	another	91.		This	switch	
requires	several	histone	modifying	complexes	in	order	to	adequately	respond	to	environmental	stimuli	
in	a	controlled	fashion205.		Chromatin	remodeling	complexes	are	not	only	responsible	for	post-
translation	modifications	of	histones	but	also	transcription	machinery	like	the	RNA	polymerase.		Such	
modifications	control	the	expression	of	early	phase	response	genes	like	TNFα	and	IL1β	during	acute	
inflammatory	reactions	206.	Also,	toll-like	receptor	signaling	(TLR)	induced	histone	acetylation	is	
necessary	for	the	induction	of	tolerance	that	occurs	as	a	result	of	inflammatory	gene	activation	207.		The	
kinetics	of	histone	modifications	are	central	to	the	resolution	of	the	inflammatory	response	and	the	
protection	of	healthy	brain	tissue	206,207.		
Table	6:	Top	Upregulated	and	Downregulated	proteins	
Fold	change	 ID	 Entrez	Gene	Name	
21.553	 Cyba	 cytochrome	b-245,	alpha	polypeptide	
16.640	 Vps52	 VPS52	GARP	complex	subunit	
10.753	 Rab8b	 RAB8B,	member	RAS	oncogene	family	
10.022	 Sfn	 stratifin	
8.433	 Prkar1a	 protein	kinase,	cAMP-dependent,	regulatory	subunit	type	I	
alpha	
6.800	 Mobp	 myelin-associated	oligodendrocyte	basic	protein	
5.956	 Pyhin1	 interferon,	gamma-inducible	protein	16	
5.040	 Fth1	 ferritin,	heavy	polypeptide	1	
4.621	 Plec	 plectin	
-5.991	 Hist1h1b	 Hist1h1b	
-5.815	 Mapk14	 MAPK14	
-5.429	 Ipo9	 IPO9	
-4.699	 Cryba4	 CRYBA4	
-4.449	 Smarca4	 SMARCA4	
-4.438	 Fgd2	 FGD2	
-4.359	 Rab5b	 RAB5B	
-4.292	 Hsph1	 HSPH1	
-4.205	 Terf2ip	 TERF2IP	
-3.942	 Smarcd2	 SMARCD2	
Table	6:	continued	
	
4.2.4	Loss	of	Nuclear	Architecture	and	Impairments	in	RNA	processing	
		Aged	microglia	also	have	substantial	changes	in	the	architecture	of	the	nucleosome,	an	organelle	
whose	proper	function	acts	as	a	regulatory	mechanism	for	transcription	34.		Table	5	shows	a	
downregulation	of	a	number	of	proteins	involved	in	the	structure	of	the	nuclear	lumen.		The	nuclear	
envelope	is	important	for	not	only	export	and	import	of	transcription	factors	and	mRNA	from	the	
nucleus	but	the	maintenance	of	high-level	chromatin	structure	34.		This	architecture	which	includes	both	
the	nuclear	lumen	and	the	chromatin	experience	degradation	as	a	result	of	age	contributing	to	
disruptions	in	cellular	function	34.		This	is	demonstrated	in	table	5	as	proteins	involved	in	
nucleocytoplasmic	transport	and	chromatin	organization	are	downregulated	in	aged	microglia.		Changes	
in	the	nucleosome	can	affect	the	movement	of	transcription	factors	as	well	as	the	proper	processing	of	
mRNA	leading	to	age-dependent	changes	in	alternative	splicing	208.		Age-dependent	changes	in	
alternative	splicing	can	affect	the	expression	of	decoy	receptors	for	pro-inflammatory	cytokines	like	
TNFα	and	IL1β	208.	These	receptors	play	an	important	role	in	the	regulation	of	pro-inflammatory	
signaling	(27).		The	functional	analysis	in	table	5	shows	a	downregulation	of	the	constituent	proteins	of	
the	spliceosome	complex.	Nuclear	import/export	and	changes	in	the	proteasome	may	all	combine	to	
contribute	to	an	increased	number	of	dysfunctional	or	improperly	translated	proteins.		An	increase	in	
which	can	trigger	stress	responses	capable	of	inducing	apoptosis	and	low-grade	inflammation	in	immune	
cells	209.		The	upstream	analysis	in	the	next	section	identifies	two	proteins	in	particular	XBP1	and	SYVN1	
which	are	indicative	of	activation	of	the	ATF6	branch	of	the	ER	stress	signaling	pathway29.		Occurring	
concurrently	with	the	loss	of	nuclear	architecture	is	a	diminished	DNA	repair	capacity.				Priming	of	
microglia	has	been	observed	in	animal	models	deficient	in	DNA-repair	capability	35.		The	DNA	repair	Kegg	
pathway	contains	several	downregulated	proteins	in	table	5.		Breakdown	of	higher	order	chromatin	
structure	and	excessive	DNA	damage	can	both	lead	to	the	loss	of	transcriptional	control	necessary	for	
the	appropriate	polarization	of	microglia	in	response	to	environmental	stimuli.	
4.2.5	Aged	Microglia	Exhibit	a	Bioenergetic	Shift	from	Glucose	to	Fatty	Acid	Utilization.	
A	shift	from	the	utilization	of	glucose	to	fatty	acids	and	amino	acids	for	energy	production	was	first	
observed	in	the	hippocampus	of	aged	female	mice	21.		The	Brinton	group	postulated	that	this	switch,	to	
less	efficient	bioenergetic	fuels,	contributed	to	the	increased	oxidative	environment	of	the	aged	brain	
(31).		Table	5	highlights	changes	in	mitochondrial	function	that	suggest	microglia	too,	undergo	this	
transition	to	alternate	substrate	utilization	(table	5).		HADHA, HEXA, HEXB, and PLCG2 are all 
proteins whose upregulation is indicative utilization of fatty acids and ketone bodies 210.  Bioenergetic	
stress,	like	that	triggered	by	inflammation	or	nutrient	deprivation,	activate	the	protein	NRF1,	as	
observed	in	our	dataset	(table	7),	leads	to	increases	in	the	expression	of	components	of	the	electron	
transport	chain	(ETC)	and	mitochondrial	membrane	28,	this	can	be	seen	in	our	analysis	of	upstream	
regulators	(Table	7).		In	astrocytes	in	the	hippocampus	of	male	mice,	there	is	an	age-dependent	increase	
in	processes	like	lipid	catabolism,	proteolysis,	and	cholesterol	transport	22.	One	theory	put	forth	by	the	
Landfield	group	is	that	this	change	in	astrocytes	results	in	increased	cholesterol	trafficking	in	the	local	
environment	22.		One	molecular	mechanism	that	governs	the	utilization	of	the	most	abundant	nutrient	
sources,	glucose,	and	fatty	acids,	is	called	the	“Randle-cycle”129	and	is	thought	to	be	important	in	insulin	
resistance	which	increases	with	age	129.		This	shift	in	substrate	utilization	decreases	neuronal	function	
and	may	precede	cognitive	dysfunction	22.		The	consequences	of	this	shift	have	not	yet	been	studied	in	
microglia	but	there	is	an	established	connection	with	this	substrate	shift	and	oxidative	stress	and	
inflammation	131.	In addition to the increased ROS, there is also evidence that myelin phagocytosis by 
microglia can impair their function and elicit a dystrophic phenotype reminiscent of aged cells 123.  The 
number of microglia is increased in the white matter of aged brains 211 and we have observed an increase 
in several, myelin-related proteins.  It is possible that microglia, as well as astrocytes, contribute to 
increased cholesterol trafficking that contributes to neuronal dysfunction with age.  This is supported by 
the identification of APOE as an upregulated protein in aged microglia (table 6).  Myelin-oligodendrocyte 
basic protein is the third most abundant myelin protein in the CNS and is also upregulated ~6 fold in this 
data set (table6) 158.  One study demonstrated that even one demyelination event can increase insoluble 
lysosomal myelin aggregates in microglia and result in an upregulation of markers of activation like 
MHCII 123.  Unlike in astrocytes, a direct link between the Randle-cycle shift and phagocytosis of myelin 
by microglia has not been identified.  However, metabolic reprogramming is a central feature of 
macrophage and microglial polarization 212.  While the consequences of a “Randle-cycle” shift in 
microglia are not fully elucidated it is plausible that it would have a meaningful impact on cellular 
function similar to the one seen in neurons. 	
4.2.6	Pathway	Clustering	and	Upstream	Regulators	
	“Upstream	regulatory	analysis	is	to	identify	molecules	upstream	of	proteins	in	the	dataset	that	
potentially	explain	observed	expression	changes”213		Ingenuity	uses	statistical	methods	to	determine	
and	score	regulators	whose	network	connections	are	unlikely	to	happen	in	a	random	model.		The	p-
value	of	overlap	scores	the	enrichment	of	network	connected	genes	for	a	particular	molecule.		While	the	
activation	z-score	identifies	molecules	using	a	statistically	significant	pattern	match	of	up	and	down	
regulation,	the	z-score	also	predicts	the	activation	state	of	the	putative	regulator.		The	primary	objective	
of	this	analysis	is	to	identify	molecules	whose	activity	has	broad	effects	on	the	cellular	systems	that	are	
altered	in	the	data	set	(Table	7).		To	that	end,	and	to	gain	an	understanding	of	the	pathways	that	
constituted	the	many	functions	discussed	in	the	previous	section	we	first	used	Ingenuity	to	create	a	map	
of	overlapping	canonical	pathways	(Figure	9).		The	top	25	canonical	pathways	significance	of	overlap	
were	arranged	according	to	shared	proteins,	an	indicator	of	co-regulation.		Figure	2	lists	three	clusters	of	
pathways	that	are	categorized	according	to	function	and	downstream	biology.		Cluster	1	is	
predominated	by	pathways	involved	in	phagocytosis	and	cytoskeletal	reorganization.	Cluster	2’s	
pathways	include	oxidative	phosphorylation	and	the	TCA	cycle,	clearly	dealing	with	mitochondrial	
function.		Finally,	in	the	third	cluster	several	catabolic	pathways	involved	in	the	degradation	of	amino	
acids	and	the	oxidation	of	fatty	acids	and	ketones.		These	clusters	clearly	mirror	the	biology	discussed	in	
the	previous	section	and	give	a	jumping	off	point	for	the	identification	of	upstream	regulators	capable	of	
influencing	the	biology	of	each	cluster.		To	further	illustrate	this	we	used	IPA	to	illustrate	the	
interactions	of	the	proteins	identified	with	each	of	the	clusters	with	top	upstream	regulators	associated	
with	the	proteins	in	each	cluster	(Figure	9).		Predicted	upstream	regulators	are	in	blue	(predicted	
inhibition)	or	orange	(predicted	activation).			Proteins	detected	in	our	dataset	in	each	cluster	leading	to	
these	predictions	are	illustrated	in	red	(upregulated)	or	green	(downregulated).	
Cluster	1	
The	highest	proportions	of	proteins	in	cluster	1	enriched	for	phagosome	maturation	and	FCγ	receptor-
mediated	phagocytosis	(Figure	9)	the	remaining	pathways	in	the	cluster	involve	some	form	of	actin	
polymerization	and	remodeling.		The	two	principal	mechanisms	of	phagocytosis	are	CR3	and	FCγ	
mediated	214.			CR3	can	phagocytose	complement	opsonized	or	unopsonized	targets	while	FCγ	requires	
prior	opsonization	by	antibodies	214.		FCγ	mediated	phagocytosis	is	accompanied	by	pseudopod	
extension,	respiratory	burst,	and	production	of	cytokines	including	TNFα	214.				FCγ	binding	activates	
Cdc42/Rac	signaling	which	is	responsible	for	the	polymerization	of	actin	in	lamellipodia	and	filopodia	
characteristic	of	FCγ	phagocytosis	214.		Activation	of	Cdc42/Rac	leads	to	the	upregulation	of	P38	map	
kinase,	activation	of	NFκB,	and	subsequent	upregulation	of	the	NADPH	oxidase	enzyme	complex	
responsible	for	the	respiratory	burst	215.		Upstream	analysis	of	this	cluster	provided	a	list	of	potential	
regulators	the	majority	of	which	(5	of8)	were	related	to	cytokine	signaling	(Figure	9).		The	aged	brain	is	
characterized	by	higher	levels	of	pro-inflammatory	cytokines	making	it	plausible	that	increased	
phagocytosis	is	occurring	as	a	result	of	an	on-going	immune	response	91.		Cdc42	is	also	listed	an	
activated	upstream	regulator	supporting	the	involvement	of	the	FCγ	receptor.		Rictor	and	MYC	also	
appear	as	regulators	upstream	of	proteins	involved	in	the	formation	of	the	lysosome.		Lysosomes	play	a	
role	in	cellular	homeostasis	and	nutrient	sensing	through	the	interaction	of	TFEB	and	mTOR	217.			The	
mTOR	pathway	is	involved	in	the	innate	immune	response	and	can	be	activated	by	signals	from	several	
receptor	types	including	TLR’s	and	scavengers	218.		In	the	previous	section	evidence	for	the	increased	
phagocytosis	of	myelin	was	presented.		Increased	expression	of	the	MHCII	receptor	is	greater	in	the	
white	matter	of	the	aged	brain	and	may	correlate	with	the	enhanced	degradation	of	myelin	91.		While	
CR3	is	considered	to	be	the	principle	means	by	which	myelin	is	phagocytosed	by	microglia,	other	
receptors	including	FCγ	have	also	been	shown	to	be	involved	106,219.			
	
	
Table	7	Upstream	Regulator	Analysis	
Top	Regulators	by	
p-Value	
	 Activated	
Regulators	
	 	
Upstream	Regulator	 Type	 Upstream	
Regulator	
Type	 Z-Score	
RICTOR	-	 Kinase	 INSR	 kinase	 3.430	
MYC-		 transcription	
regulator	
IFNG	 cytokine	 3.369	
NRF1		 transcription	
regulator	
IKBKB	 kinase	 3.135	
NFE2L2		 transcription	
regulator	
APP	 other	 3.112	
TP53-		 transcription	
regulator	
NRF1-		 transcription	
regulator	
2.937	
INSR	-		 kinase	 TP53-		 transcription	
regulator	
2.573	
TGFB1-	 growth	factor	 XBP1-		 transcription	
regulator	
2.558	
CDC42-		 enzyme	 Ins1-		 other	 2.538	
IGF1R-	 transmembrane	
receptor	
Cdc42-		 enzyme	 2.449	
NR3C1-	 nuclear	receptor	 STAT3-		 transcription	
regulator	
2.320	
SOD-	 enzyme	 TNF-		 cytokine	 2.289	
Map4k4-	 kinase	 TFEB-		 transcription	
regulator	
2.215	
KDM5A-	 transcription	
regulator	
STAT1	 transcription	
regulator	
2.200	
PPAR-1	 	nuclear	receptor	 IGF1R	 transmembrane	
receptor	
2.121	
IL1β-	 cytokine	 CHUK	 kinase	 2.061	
MTOR-	 kinase	 IL3	 cytokine	 2.000	
IFNG-	 cytokine	 MKNK1	 kinase	 2.000	
TNF-	 cytokine	 	 	 	
Inhibited	Regulators	 	 	 	 	
Upstream	Regulator	 Type	 Z-Score	 	 	
RICTOR-		 Kinase	 -2.837	 	 	
mir-21-		 microrna	 -2.200	 	 	
VCAN-		 other	 -2.000	 	 	
Table	7	continued	
	
	
	
Figure	9:		Canonical	Pathways	form	“clusters:	of	interdependence.		The	table	on	above	contains	the	
name	of	each	pathway	in	the	cluster,	as	well	as	the	proteins	for	which	the	pathway	enriches.			To	illustrate	the	
interrelationships	of	the	proteins	in	each	cluster	with	upstream	regulators	determined	by	IPA,	the	proteins	that	
enriched	for	the	pathways	in	clusters	1,	2,	and	3	as	well	as	upstream	regulators	were	visualized	as	a	network	using	
IPA.		Downstream	proteins	that	were	detected	in	the	proteomics	experiment	are	denoted	by	fold	change	and	p-
values	beneath	them.		Red	color	indicates	an	upregulation	and	green	a	downregulation	with	a	color	intensity	
related	to	expression	value.		Upstream	regulators	are	listed	in	the	table	to	the	right	of	the	figure	and	contain	the	
downstream	proteins	affected.			
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Cluster	2	
Cluster	2	contains	pathways	involved	in	mitochondrial	function	including	oxidative	phosphorylation,	the	
TCA	cycle,	and	NRF2-mediated	oxidative	stress	response	(Figure	9).		One	upstream	regulator	NRF1	is	
responsible	for	the	transcription	of	nuclear	mitochondrial	genes,	including	components	of	the	ETC	28.		
NRF1	is	a	downstream	target	of	MYC	but	can	also	be	activated	through	chronic	activation	of	AMPK	due	
to	bioenergetics	stress	28,220.		A	protein	in	the	TCA	pathway,	OGDH	is	downstream	of	the	insulin	receptor	
and	involved	in	the	conversion	of	alpha-ketoglutarate	to	succinyl-CoA	and	is	indicative	of	utilization	of	
ketones	in	the	Krebs	cycle	21.	The	increase	in	mitochondrial	subunits	via	NRF1	may	be	related	to	the	shift	
to	ketones	as	an	energy	source.		Ketones	and	fatty	acids	are	less	efficient	than	glucose	as	energetic	
substrates,	producing	more	ROS	per	unit	ATP	130.		The	Randle	Cycle,	a	shift	to	the	most	abundant	
substrate	available,	under	normal	circumstances,	can	be	overridden	through	the	signaling	of	AMPK	
which	is	activated	during	periods	of	nutrient	scarcity	220.	In	fact,	the	AMPK	activity	is	upstream	of	NRF1	
and	activates	during	energetic	stress	220.		It	is	possible	that	disruptions	in	parallel	nutrient	sensing	
pathways	like	mTOR	are	interfering	with	the	cells	ability	to	utilize	glucose.		Nutrient	responsive	
pathways	predominate	the	upstream	regulators,	with	insulin,	mTOR,	Rictor	and	peroxisome	proliferator-
activated	receptor	alpha	pparα	signaling	all	implicated	in	this	cluster.		NFE2L2	is	also	present	as	a	
predicted	regulator,	upstream	of	proteins	involved	in	response	to	oxidative	stress	(table	7).		KDM5A	also	
known	as	JARD1A	is	a	histone	3	lysine	4	demethylase	that	binds	to	several	nuclear	transcription	factors	
including	c-myc,	pgc-1a,	and	the	tumor	suppressor	protein	pRB.		Loss	of	KDM5A	increases	mitochondrial	
respiration	as	KDM5A	is	a	direct	repressor	of	metabolic	regulator	genes	221.	Both	nutrient	sensing	and	
histone	modifying	pathways	are	altered	with	age	as	reviewed	183.		Cluster	2	demonstrates	direct	links	
between	these	pathways	and	mitochondrial	function.		It	is	unclear	how	these	mitochondrial	changes	
contribute	to	the	aged	microglial	phenotype.	However,	increased	NRF2	signaling	may	be	an	indicator	of	
increased	mitochondrial	ROS	production	an	indicator	of	mitochondrial	dysfunction.			
Cluster	3	
Perhaps	the	most	interesting	cluster,	this	group	of	pathways	governs	the	conversion	of	metabolic	
intermediates	into	substrates	for	oxidative	phosphorylation	(Figure	9).		Dominant	here	are	proteins	
responsible	for	the	breakdown	of	amino	acids	and	the	conversion	of	ketone	bodies	into	succinyl-CoA.		In	
addition	to	the	utilization	of	amino	acids,	this	cluster	is	enriched	for	proteins	necessary	for	the	oxidation	
of	fatty	acids.		Upstream	of	these	proteins	are	some	predictable	pathways	like	mTOR,	PPARα/γ,	and	the	
insulin	receptor	(Figure	9).		These	pathways	govern	a	large	network	of	metabolic	genes	that	control	the	
shuttling	and	processing	of	macromolecules	used	in	bioenergetics	processes	80,181,222.		The	second	group	
of	upstream	regulators	are	mediators	of	the	inflammatory	response	and	include	TGFβ,	p53,	and	
map4k4.		Map4k4	facilitates	the	signal	transduction	of	TNFα	signaling	while	p53	is	a	transcriptional	
regulator	involved	in	NFκB	signaling	223,224.		Seeing	the	involvement	of	inflammatory	mediators	upstream	
of	these	pathways	suggests	that	this	shift	in	substrate	utilization	may	be	due	to	an	ongoing	
inflammatory	process.		There	is	currently	no	evidence	that	acute	activation	of	microglia	triggers	this	shift	
although	metabolic	reprogramming	is	a	central	component	of	innate	immune	cell	polarization	225.		While	
TLR4	activation	has	been	shown	to	shift	innate	immune	cells	towards	reliance	on	glycolysis,	this	has	not	
been	observed	by	activators	other	than	LPS	225.		In	fact,	this	cluster	is	more	consistent	with	the	
alternative	activation	of	macrophages,	which	is	regulated	by	the	PPAR’s	and	relies	on	oxidation	of	fatty	
acids	vs	glycolysis	226.		This	is	consistent	with	the	idea	that	phagocytosis	is	a	function	of	alternatively	
activated	microglia	but	contrary	to	data	suggesting	aged	microglia	are	polarized	to	the	M1	phenotype	
112.		This	embodies	the	inherent	complexity	of	microglial	polarization	and	underlies	the	difficulty	in	
defining	“activation	states”	of	the	cells	based	on	observations	made	in	vitro.			
The	goal	of	this	upstream	analysis	was	to	find	proteins	capable	of	affecting	underlying	biology	through	
their	interaction	with	the	various	affected	cellular	systems.		Rictor,	the	primary	component	of	the	
mTORC2	complex	was	the	top	scoring	regulator	with	respect	to	both	z-score	and	p-value.		mTORC2	was	
thought	to	mostly	govern	actin	dynamics	and	cell	movement	but	has	recently	been	found	to	influence	
both	glycolytic	metabolism	and	mitochondrial	physiology	227-229.		In	this	analysis,	RICTOR	was	directly	
implicated	in	2	of	3	clusters	and	more	broadly	mTOR	signaling	was	predicted	to	regulate	at	least	one	
pathway	in	each	cluster.		Nutrient	sensing	pathways	and	mTOR,	in	particular,	play	a	central	role	in	the	
activation	of	innate	immune	cells	218.		This	finding	suggests	that	targeting	RICTOR	may	prove	useful	in	
attenuating	age-dependent	changes	in	cellular	function.	
	4.2.7	mTORC2	validation	as	an	upstream	regulator.	
The	priming	of	microglia	likely	contributes	to	both	the	development	and	progression	of	
neurodegenerative	disease	230.		In	addition,	the	age-dependent	increase	in	baseline	expression	of	pro-
inflammatory	cytokines	contributes	to	the	age-dependent	decline	in	cognitive	function	116,231,232.		This	
makes	the	dysregulated	polarization	of	microglia	a	primary	target	for	the	treatment	of	cognitive	
dysfunction	underlying	both	normal	aging	and	neurodegenerative	disease.		As	this	study	has	thus	far	
outlined	the	causes	of	age-dependent	microglial	dysfunction	are	many	and	unlikely	to	be	completely	
resolved	in	the	near	future.		However,	identifying	key	pathways	able	to	modulate	phenotype	in	aged	
cells	was	a	primary	goal	of	this	study.		The	mTORC2	pathway	was	the	top	scoring	upstream	regulator	
with	respect	to	both	Z-score	and	p-value,	in	addition,	it	had	the	highest	diversity	of	proteins	and	
canonical	pathways	in	the	dataset	that	was	responsible	for	the	predicted	down-regulation	of	activity	
gure	10).		A	literature	review	of	mTOR’s	role	in	inflammation	underscores	a	role	for	mTORC2	in	the	
	
	
Figure	10:	RICTOR	is	Upstream	of	Multiple	Canonical	Pathways.	(A)	Rictor	and	its	downstream	proteins	
displayed	as	a	network.		Symbol	color	represents	expression	value	red	indicating	an	up-regulation	and	blue/Green	indicating	
downregulation	in	our	dataset.			Rictor	modulates	the	expression	or	function	of	downstream	proteins	listed	in	the	figure.		The	
aggregate	expression	values	of	data	set	proteins	contribute	to	a	predicted	decrease	in	RICTOR	activity.	(B)	Proteins	downstream	
of	Rictor	can	be	grouped	into	five	canonical	pathway	groups	and	4	families.		The	identified	pathways	are	also	included	in	the	
top	five	pathways	identified	as	affected	by	age.	
	
regulation	of	innate	immune	activation	23,168,233.	mTOR	the	mammalian	target	of	rapamycin	exists	in	two	
distinct	complexes	mTORC1	and	mTORC2	characterized	by	differing	central	components	RAPTOR	and	
RICTOR	respectively	234.		The	mTOR	pathway	senses	nutrient	abundance	and	is	a	master	regulator	of	
cellular	metabolism	and	growth	234.		mTOR	is	also	required	for	cytokine-dependent	microglial	activation	
as	demonstrated	in	the	BV2	cell	line235.		mTOR	exerts	influence	over	innate	immune	cell	activation	
through	its	coordination	of	the	metabolic	reprogramming	that	occurs	during	polarization	218.		Although	
the	mechanism	by	which	mTORC2	specifically	exerts	its	effect	on	microglia	is	unknown,	several	studies	
offer	potential	downstream	actions	that	may	regulate	inflammatory	pathways.		These	include	mTORC2’s	
action	to	phosphorylate	AKT	at	serine	473	which	is	required	for	its	activity	to	regulate	both	FOXO1	and	a	
network	of	micro	RNA's	responsible	for	regulation	of	the	pro-inflammatory	response	233,236.	To	confirm	
that	mTORC2	activity	is	diminished	in	aged	microglia	we	performed	a	western	blot	analysis	of	young	and	
aged	primary	microglia	from	C57BL/6N	mice	(figure	11	A-D).		We	show	a	diminished	level	of	Rictor	
protein	in	the	isolated	primary	microglia	of	aged	mice	(11	A,	B).			mTORC2	is	regulated	by	nutrient	
sensing	pathways	involved	in	energy	regulation	as	both	insulin	and	IGF	have	been	shown	to	trigger	
mTORC2	dependent	phosphorylation	of	AKT	at	serine	473	237.		We	examined	this	in	our	isolated	primary	
microglia,	both	at	baseline	and	15	minutes	post-IGF	exposure	aged	microglia	had	significantly	lower	
phosphorylation	AKT	at	S473,	this	is	consistent	with	the	literature	for	the	aging	brain	238	and	the	
prediction	made	by	IPA	(figure	11	C,	D).	To	determine	whether	diminished	mTORC2	activity	was	
sufficient	to	induce	an	inflammatory	response	similar	to	that	of	aged	microglia	we	used	a	siRNA	specific	
for	RICTOR	in	BV2	cells	and	compared	that	with	the	baseline	and	TNFa	and	IL4	stimulated	the	response	
of	primary	microglia	from	young	and	aged	mice.	The	profile	of	RICTOR	knockdown	cells	shared	
significant	overlap	with	aged	primary	cells	who	at	baseline	have	increased	expression	of	TNFa,	IL1b	and	
IL6	(figure	11	E,	H).		Further	similarity	is	observed	when	cells	were	exposed	to	the	pro-inflammatory	
cytokine	TNFα.		Both	aged	cells	and	BV2	cells	with	diminished	mTORC2	activity	had	higher	levels	of	IL1β	
and	IL6	(figure	11	F,	I).		It	was	worth	noting	that	both	after	TNF	treatment	the	M1	gene	marco	exhibited	
reciprocal	expression	between	groups.		Another	feature	of	aged	microglia	is	a	failure	to	upregulate	anti-
inflammatory	molecules	indicative	of	an	alternative	activation.	Aged	microglia	exhibit	a	decreased	
upregulation	of	both	arginase	1	and	fizz1	while	showing	no	change	in	IGF	and	an	increase	in	the	gene	
YM-1	(figure	11G).		Microglia	with	diminished	mTORC2	activity	exhibited	a	strikingly	similar	profile,	
induction	of	both	arginase	1	and	fizz1	were	blunted	in	these	cells	and	expression	of	YM-1	was	higher	
than	cells	with	scramble	treated	control	(figure	11J).			
While	these	results	are	promising,	we	examined	a	significant	but	limited	subset	of	genes	that	delineate	
between	pro	and	anti-inflammatory	states	of	the	cell206.		Other	factors	such	as	phagocytic	activity,	ROS	
production,	and	neurotrophic	factor	production	are	features	of	microglial	activation	that	affect	the	
development	of	age-dependent	disease	presentation	and	progression	171.		Still,	these	results	were	
significant	enough	to	warrant	further	experimentation	into	whether	modulation	of	mTORC2	would	be	
an	effective	method	by	which	to	attenuate	age-dependent	priming.			
4.3 Conclusion 
Primed	microglia	have	been	described	in	both	aging	and	neurodegenerative	disease	230.		They	are	
characterized	as	having	hypersensitive	responses	to	pro-inflammatory	stimuli,	diminished	responses	to	
immunomodulatory	molecules,	impaired	phagocytic	capability,	and	a	dystrophic	morphology	124,230.		It	is	
believed	that	this	priming,	contributes	to	the	progression	of	neurodegenerative	diseases	including	AD,	
Parkinson’s,	depression,	and	Multiple	Sclerosis	44,91.		Microglia	are	remarkably	versatile	cells	exhibiting	a	
wide	range	of	activation	states	that	have	been	characterized	using	the	M1	classical	and	M2	alternative	
states115,	however,	it	is	widely	recognized	that	this	does	not	fully	describe	the	pleiotropic	nature	of	the	
response	of	microglia	to	the	environment.		This	versatility	is	a	necessary	component	for	microglia	to	
maintain	a	homeostatic	environment	through	adept	communication	with	their	environment.		In	one	
sense,	aging	represents	a	loss	of	that	adaptability	characterized	in	part,	by	the	loss	of	transcriptional	
control	over	their	responses.		The	molecular	mechanisms	responsible	for	this	age	specific	phenotype	
sometimes	referred	to	as	priming	remain	unknown,	although	the	transcriptional	profile	of	these	cells	is	
becoming	clearer	136.		The	transcriptome	of	aged	microglia	significantly	overlaps	with	that	of	microglia	
found	in	degenerative	disease,	but,	to	no	surprise,	bears	little	relationship	to	that	of	either	classical	or	
alternatively	activated	cells	113,124,169.			
		
	
Figure 11: Age-dependent decrease in mTORC2 contributes to pro-inflammatory 
phenotype.	(A)	Protein	analysis	using	the	Wes	instrument	(Protein	Simple)	analyzing	levels	of	RICTOR	in	primary	microglia.	
(B)	Graph	representing	measurements	from	RICTOR	western	show	aged	microglia	have	diminished	levels	of	the	RICTOR	protein.		
(C)	Primary	microglia	from	male	young	(5-7	months)	and	old	(20-24	months)	were	treated	with	100	ng/ml	IGF	for	15	min	and	
then	proteins	samples	analyzed	for	AKT	and	AKTp473.	(D)	Analysis	of	intensity	measurements	received	from	the	WES	indicate	
pAKT	activation	by	IGF	is	lower	in	aged	microglia.	(E)	Pcr	analysis	of	primary	microglia	shows	increased	M1	gene	expression	at	
baseline.	(F)	Primary	microglia	stimulated	with	20	ng/ml	TNFα	for	24	hours.		Aged	cells	had	significantly	higher	levels	of	IL1β,	
IL6,	and	Marco.(G)	Young	and	old	primary	microglia	treated	with	20	ng/ml	IL4	for	24	hours.	Aged	microglia	exhibited	lower	
expression	of	IGF1	and	Fizz	genes.	(H)	BV2	microglia	(48	hour	Rictor	siRNA	exposure)	have	higher	baseline	levels	of	pro-
inflammatory	genes:	TNFα,	IL6,	Marco.	(I)	BV2	cells	(siRNA	Rictor	48	hours)	treated	with	TNFα	had	higher	levels	of	M1	gene	
expression	IL1β,	IL6	than	a	scramble	control	group.		(J)	BV2	cells	pretreated	with	siRNA	and	scramble	RNA	for	48	hours	and	
subsequently	treated	with	IL4	(20	ng/ml)	for	24	hours	had	lower	expression	of	M2	genes	Arg1	and	Fizz1.	Fold	changes	for	
baseline	are	reported	are	relative	comparisons	using	Young/Scramble	as	a	control.		Interpreted	as	“IL6	is	10	fold	higher	in	old	
microglia	at	baseline	as	compared	to	young	microglia.		N=3	replicates	per	experiment,	three	independent	experiments	
performed.			For	the	TNFa	and	IL4	stimulation	experiments	data	is	represented	as	the	ratio	of	fold	change	from	age/treatment	
matched	control.			
 
One	goal	of	this	study	was	to	better	define	the	molecular	pathways	that	contribute	to	the	aged	
phenotype.		Aged	microglia	have	a	marked	decline	in	cellular	systems	responsible	for	transcriptional	
control.		These	include	the	nucleosome,	spliceosome,	and	complexes	responsible	for	the	maintenance	
and	modification	of	chromatin	(table	5).		Induction	of	tolerance	to	inflammatory	stimuli	is	one	of	the	
earliest	events	the	in	inflammatory	signaling	and	is	dependent	on	modification	of	histones	to	restrict	
transcription	factor	access	genes	that	drive	the	response	205.		In	addition	to	a	loss	of	regulatory	control	
aged	microglia	exhibit	impaired	DNA	repair	capability	(table	5).		Models	of	priming	in	DNA-repair	
deficient	microglia	have	significant	phenotypic	overlap	with	that	of	aged	microglia	35.		Whether	or	not	
these	changes	result	directly	in	the	hypersensitivity	observed	with	age	they	likely	contribute	to	other	
maladaptive	changes	observed	in	microglia.		A	central	component	of	the	microglia	shift	in	phenotype	
involves	the	reprogramming	of	metabolic	networks	that	involves	the	mTOR	pathway.		The	data	
presented	in	this	study	suggests	aged	microglia	have	shifted	from	the	use	of	glucose	to	the	oxidation	of	
ketones	and	fatty	acids	for	energy.		While	this	has	been	observed	in	other	cell	types	in	the	aged	brain,	
this	is	the	first	time	it	has	been	identified	in	a	purified	microglial	population	22.		Long	term	use	of	these	
substrates	can	lead	to	increased	mitochondrial	ROS	and	may	be	indicative	of	loss	of	insulin	sensitivity	
22,181,239.		Subsequently,	this	study	has	identified	changes	in	two	cellular	systems	that	have	the	ability	to	
directly	impact	the	phenotype	of	aged	microglia.	
What	influence	the	environment	plays	on	the	age-related	changes	in	microglia	is	currently	
unknown.		It	is	theorized	that	on-going	low-grade	inflammation	contributes	to	the	priming	of	microglia	
230.		The	upregulated	functions	in	this	analysis	suggest	microglia	are	actively	migrating	and	
phagocytosing	substances	in	their	environment.		Myelin	basic	protein	was	upregulated	~7	fold	in	aged	
microglia	suggesting	that	this	is	the	substance	microglia	are	actively	engulfing	(table	6).		Microglial	
density	is	higher	in	the	white	matter	of	aged	brains	and	myelin	degradation	positively	correlates	with	
both	age	and	markers	of	microglia	activation	91,240.		Recent	studies	suggest	that	the	degradative	capacity	
of	microglia	for	myelin	is	reached	in	mid-life	123.		Aged	microglia	are	immunopositive	for	non-soluble	
aggregates	of	myelin	in	lysosomes	123.		This	study	also	showed	that	this	aggregate-induced	lysosomal	
dysfunction	induces	an	age-like	phenotype	in	microglia	123.		In	this	example	at	least,	the	on-going	
pathology	of	myelin	degradation	in	the	environment	is	capable	of	driving	transcriptomic	changes	that	
resembled	that	of	aged	cells.		Although	the	question	remains	if	prior	dysfunction	of	the	microglia	itself	is	
to	blame	for	the	degradation	of	the	myelin.			
As	chronic	inflammation	is	a	hallmark	of	the	degenerative	disease	process,	it	is	also	a	target	for	
therapeutic	intervention.		The	identification	of	RICTOR	as	an	upstream	regulator	of	several	affected	
systems	presented	an	opportunity	to	study	both	of	the	role	of	this	pathway	in	microglial	aging	and	it’s	
potential	as	a	therapeutic	target.		Diminished	mTORC2	activity	affects	several	cellular	systems.		Where	
this	presents	a	challenge	for	defining	a	mechanism	of	action,	it	presents	an	opportunity	for	reversing	
phenotype.		It	is	possible	that	each	change	discussed	in	this	section	contributes	a	fraction	to	the	overall	
phenotype	of	the	aged	cell.		However,	the	knockdown	the	mTORC2	was	able	to	recapitulate	a	significant	
portion	of	the	phenotype.		This	may	mean	that	upstream	changes	converge	at	mTORC2,	or	that	several	
smaller	changes	occur	downstream	of	mTORC2	within	its	regulatory	network.		In	any	case,	this	study	has	
thoroughly	examined	the	phenotype	of	the	aged	microglia	and	proposed	several	new	theories	regarding	
the	priming	of	these	cells.		Future	work	will	continue	the	validation	of	other	regulators	in	this	study	to	
better	understand	how	the	complex	signaling	networks	interact	in	the	aged	environments.	
4.4 Experimental Procedures 
Cell	Culture	and	Treatments	
Primary	microglia	was	grown	in	base	media	of	DMEM	supplemented	with	F12,	10%	heat-inactivated	
fetal	bovine	serum,	glutamine	(glutamax	2mM),	100	µg/ml	penicillin,	and	100	U/ml	streptomycin.		Cells	
were	allowed	3	days	in	culture	at	which	time	dendritic	arbors	representative	of	a	resting	phenotype	
were	easily	discernible.		For	phosho	studies,	cells	were	cultured	overnight	in	DMEM	as	described	above	
with	only	1%	FBS.		After	serum	starvation,	cells	were	treated	with	100	ng/ml	IGF	in	serum	free	media	for	
15	minutes	prior	to	lysis	with	RIPA	buffer	supplemented	with	calyculin	a	and	protease	inhibitors.		For	
westerns	assessing	phenotypes	cells	were	cultured	overnight	in	1%	FBS	DMEM.		Cells	were	subsequently	
treated	with	20	ng/ml	TNFα	and	IL-4	(Sigma)	for	24	hours.			
Primary	Microglia	Extraction	
Primary	microglia	was	obtained	from	young	(3-5)	month	and	old	(20-24)	month	old	male	animals.		Mice	
were	euthanized	with	C02	according	to	IACUC	standard	protocol.		A	single	cell	suspension	was	obtained	
using	Miltenyi	Biotec’s	neural	tissue	disassociation	kit	(P)	(130-093-231).	Briefly,	brains	were	removed	
and	placed	in	cold	HBSS	w/o	ca+	mg+	ice.		Using	a	scalpel	the	brains	were	mechanically	disassociated	in	
a	petri	dish	then	transferred	to	a	15	ml	tube	and	spun	at	200g	for	two	minutes.		The	tissue	was	
enzymatically	digested	according	to	manufacturer’s	protocol	to	obtain	a	single	cell	suspension.		Primary	
microglia	were	isolated	using	Miltenyi	Biotec’s	LS	magnetic	columns	and	CD11b	magnetic	beads	
(130042401	and	130093634	respectively).			This	procedure	yielded	between	200k	and	300k	cells	with	
95%	purity	as	confirmed	by	ICC.			
Super-SILAC	processing	and	mass	spectrometric	analysis	
Prior	to	lysis	cells	were	washed	with	PBS	and	collected	with	a	rubber	cell	scraper.		Cells	were	then	lysed	
in	4%	SDS	in	100mM	Tris-HCL,	pH	7.6	and	100	mM	dithiothreitol	at	95°C	for	4	min.	The	Super-SILAC	BV-2	
internal	standard	was	prepared	by	culturing	immortalized	mouse	microglia	in	SILAC	DMEM	
supplemented	with	10%	SILAC	dialyzed	FBS,	1	ml	of	100x	PSG,	and	100	mg/L	each	of	heavy	13C6	lysine	
and	13C6,	15N4	arginine.		Seven	doublings	were	allowed	to	achieve	proper	incorporation	before	24	hours	
in	serum	free	media.		Separate	flasks	were	then	treated	with	30	ng/ml	LPS,	30	ng/ml	IL-4	and	10	ng/ml	
IL-13,	10	ng/ml	IL-10,	or	50	mM	ethanol	for	24	hours,	in	addition	to	untreated	cells.		Cells	were	lysed	in	
4%	SDS,	100	mM	Tris-HCl,	pH	7.6,	100	mM	dithiothreitol	for	5	minutes	at	95°	C	prior	to	probe	sonication	
and	clearance	of	lysate	via	15000	g	microcentrifugation	for	5	minutes.		A	protein	assay	was	performed	
via	660	nM	protein	assay	with	ionic	detergent	compatibility	reagent	and	lysates	combined	together	in	
equal	protein	amount	to	create	the	internal	standard.		Microglia	isolated	from	young	and	old	mice	were	
processed	using	the	same	approach.		Equal	quantities	of	the	stable	isotope-labeled	BV2	internal	
standard	were	added	to	the	microglial	cell	lysates	and	digested	via	the	FASP	procedure241.	Briefly,	cells	
were	exchanged	into	9	M	urea	and	alkylated	with	10	mM	iodoacetamide	in	a	30	kDa	Microcon	Forensic	
Column	(Millipore)	across	multiple	14,000xg	centrifugations	prior	to	exchange	into	25	mM	ammonium	
bicarbonate.		Proteins	were	digested	overnight	using	a	1:100	ratio	of	Mass	Spectrometry	Grade,	TPCK-
treated	trypsin	(Promega)	prior	to	collection	into	a	new	tube.		Samples	were	desalted	on	C18	SPE	
columns,	concentrated	in	a	vacuum	concentrator,	resuspended	in	0.1%	formic	acid	prior	to	mass	
spectrometric	analysis.	
	 Microglia	digests	were	separated	on	an	Acclaim	PepMap	C18	(75	µm	x	50	cm)	UPLC	column	
(Thermo)	using	an	EASY-nLC	1000	with	a	gradient	time	of	120	min	(2-40%	acetonitrile	in	0.1%	formic	
acid).		Mass	spectrometric	analysis	was	carried	out	on	a	hybrid	quadrupole-Orbitrap	instrument	(Q	
Exactive	Plus,	Thermo)	using	data-dependent	acquisition	in	which	the	top	10	most	intense	ions	were	
selected	for	MS/MS.	Full	scan	and	MS/MS	resolution	were	70,000	and	17,500,	respectively.		Peptide	and	
protein	identifications	were	assigned	through	MaxQuant	(version	1.5.0.30)	using	the	UniProt	Homo	
sapiens	database	(downloaded	September	2014).		Acetylation	(protein	N-terminus)	and	oxidation	of	
methionine	were	set	as	default	variable	modifications.		Additional	variable	modifications	included	N-
ethylmaleimide	(NEM),	N-methylmaleimide	(NMM)	and	carbamidomethylation	(CAM)	of	cysteine	(Cys)	
residues.		Other	database	search	parameters	included	trypsin/P	as	the	enzyme	used	with	the	possibility	
of	two	missed	cleavages	and	20	ppm	(first	search)/4.5	ppm	(recalibrated	second	search)	mass	tolerance	
for	precursor	ions	and	20	ppm	mass	tolerance	for	fragment	ions.		Further	detection	validation	of	
modified	Cys-containing	peptides	identified	from	the	data-dependent	acquisition	was	performed	using	
targeted	MS/MS	analysis.		Targeted	MS/MS	analysis	was	carried	out	at	17,500	mass	resolution	with	an	
automatic	gain	control	target	value	of	1e6	and	maximum	ion	injection	time	of	200	ms.		The	inclusion	list	
of	all	modified	Cys-containing	peptides	for	targeted	MS/MS	analysis	was	generated	based	on	identified	
peptides	from	MaxQuant	search	results.	
Statistical,	Pathway,	and	Upstream	Regulator	Analysis	
High-resolution	mass	spectrometric	data	were	analyzed	on	the	MaxQuant	processing	suite,	version	
1.5.4.1.		Spectra	were	searched	against	the	UniProt	reference	database	for	Mus	musculus	using	the	
MaxQuant	built-in	peptide	identification	algorithm,	Andromeda.		Trypsin	was	specified	as	the	digestion	
protease	with	the	possibility	of	2	missed	cleavages.		Intensities	for	all	peptides	were	assigned	by	
MaxQuant	using	full	scan	mass	spectra,	and	ratios	between	heavy	and	light	SILAC	partners	were	
calculated.		Identifications	were	filtered	using	a	target/decoy	strategy	employing	reversed	sequences	
with	a	false	discovery	rate	of	1%	for	peptides	and	proteins.	The	MaxQuant	ProteinGroups	file	was	then	
analyzed	using	the	Perseus	(version	1.5.4.1)	processing	suite.		The	protein	list	was	log2-transformed	and	
filtered	to	include	proteins	that	contain	50%	valid	values	(i.e.,	detectable	ratio).	The	remaining	missing	
values	were	replaced	with	the	imputation	function	in	Perseus	using	default	parameters.	For	proteins	
that	did	not	generate	ratio	values	presumably	due	to	proteome	differences	between	primary	microglia	
and	BV2	cells,	the	raw	intensity	values	for	the	“light”	peptides	were	used	to	perform	label-free	
quantitation	of	relative	protein	expression	(compare.	In	both	the	SILAC	and	label-free	approaches,	
statistical	significance	was	established	at	p<0.05	using	the	Student’s	t-test	on	log2-transformed	ratios	or	
intensity	values.	Final	ratios	represent	old/young	for	each	protein	(mean,	n=5	for	old	and	n=5	for	young)	
where	SILAC-generated	ratios	were	calculated	through	a	ratio-of-ratio	calculation	and	label-free	ratios	
were	calculated	from	raw	intensity	values.	Proteins	that	were	identified	as	significant	were	entered	into	
Ingenuity	Pathway	Analysis	suite	to	determine	localization,	molecular	function,	and	protein	interaction	
pathways.	Upstream	Regulator	analysis	identifies	upstream	transcriptional	regulators	that	can	explain	
the	observed	gene	expression	changes	in	a	user’s	data	set.		For	each	potential	regulator,	two	statistical	
measures	are	taken,	an	overlap	p-value	and	activation	z-score.		The	p-value	calculates	the	overlap	
between	a	known	regulator	and	dataset	targets	of	that	gene	or	protein	through	a	Fisher’s	exact	test	
while	the	z-score	infers	likely	activation	states	based	on	a	comparison	model	242	where	z	>2	or	<2	
indicates	activation	or	inhibition,	respectively.		
RT-PCR	
After	treatment	as	described	above	cells	were	lysed	and	RNA	was	collected	using	the	rn-easy	plus	kit	
(Qiagen).		Concentration	and	quality	were	determined	using	a	nano	drop	analyzer	(Thermo).		100	nano	
grams	of	RNA	was	with	vilo	superscript	cdna	reverse	transcription	mix	(Thermo)	to	create	a	cDNA	
template.		Rt-PCR	was	performed	using	the	power	up	sybr	green	master	mix	(Applied	Biosystems)	on	a	
step-one	plus	real-time	PCR	machine	(Applied	Biosystems).		The	following	“fast”	cycling	conditions	were	
used:	2	minutes	50°,	1	minute	95°C,	95°C	15	seconds,	60°C	3	seconds	with	read,	this	was	repeated	for	40	
cycles	followed	by	a	melt	curve.		The	primers	used	were	TNFα,	IL1β,	IL6,	MARCO,	ARG1,	IGF1,	ACTB,	and	
YM1	(IDT	Primetime	Primers,	ref	seq	NM_013693,	NM_008361,	NM_031168,	NM_010766,	NM_007482,	
NM_1055770,	NM_009892)	at	a	concentration	of	500	nM.	
Western	Blot	
The	primary	cell	treatments	described	above	were	performed	and	the	cells	collected	and	lysed.		Protein	
concentrations	were	determined	by	BCA	assay.		Western	blots	were	run	using	the	Wes	from	Protein	
Simple.		This	microfluidic-based	assay	is	a	highly	quantitative	method	for	determining	protein	levels	
from	diluted	lysates.		Cell	lysates	were	diluted	to	.2µg/ml	and	run	a	size	assay	was	run	on	a	25	well	plate.		
The	assay	parameters	were	as	follows:	25	minute	separation	time,	375	volts,	5-minute	antibody	diluent,	
60-minute	primary	antibody	incubation,	and	30-minute	secondary	incubation.		The	following	antibodies	
were	used				1:50	Akt	(rabbit,	Cell	Signal),	1:50	pAKT	(s473)	(rabbit,	Cell	Signaling),	and	GAPDH	1:2000		
	 	
	
	
	
	
	
Chapter	5:	Conclusion		
Humans	are	living	longer	lives	because	of	the	accomplishments	of	modern	science.		As	a	result,	more	
adults	are	living	longer	lives	increasing	the	prevalence	of	chronic	and	degenerative	diseases.		The	
consequences	of	aging	vary	at	the	cellular	level	but	the	overall	impact	is	a	loss	of	integrity	and	function	
of	tissues	and	organ	systems.				Some	changes	that	occur	with	age,	such	as	DNA	damage,	cannot	
currently	be	reversed	with	available	technology	although	very	early	studies	have	been	attempted.			
However,	the	phenotypes	that	present	with	age	are	rarely	the	result	of	a	failure	of	a	single	cell	or	even	
cell	type.		There	has	been	substantial	evidence	showing	that	therapeutic	interventions	are	able	to	
reverse	some	age-related	impairments	and	slow	the	progression	of	others.		In	vitro,	the	blueberry	
isolate	was	able	to	attenuate	cellular	response	to	LPS	and	another	study	found	that	spirulina	was	
protective	against	MPTP-induced	parkinsonian	symptoms	56,186,246,247.			
The	overarching	focus	of	the	work	presented	in	chapter	3	was	to	provide	insight	into	how	age	affects	the	
molecular	systems	of	cells	vital	to	the	maintenance	of	cognitive	ability.			In	Chapter	3	we	examined	the	
hippocampus	which	is	a	unique	brain	structure	both	in	function	and	aging-related	gene	expression	
signature	169.		Previous	studies	of	the	hippocampus	revealed	increased	inflammatory	signaling,	our	lab's	
previous	work	concluded	that	polyphenolic	compounds	were	beneficial	in	restoring	hippocampal-
dependent	functions	as	well	as	supporting	neurogenesis.		This	presented	the	opportunity	to	further	
study	the	mechanism	by	which	these	compounds	may	achieve	this,	as	well	as	attempt	to	establish	a	
causal	link	between	specific	inflammatory	events	and	behavioral	impairments.	
A	clear	connection	has	been	previously	established	between	neurogenesis	in	the	hippocampus	and	for	
the	formation	of	new	memories	248.		Exercise	exerts	a	positive	effect	on	memory	formation	through	the	
microglial	dependent	secretion	of	the	growth	factors	BDNF	and	IGF,	both	of	which	positively	regulate	
neurogenesis	47,53.		The	coordination	between	the	microglial	cells	and	the	neural	stem	cells	in	the	
hippocampus	to	facilitate	memory	formation	led	our	group	to	focus	on	signaling	pathways	directly	
related	to	both	cell	types.		We	used	a	panel	of	genes	involved	in	WNT	signaling,	a	pro-neurogenic	
pathway	that	regulates	both	the	proliferation	and	differentiation	of	neural	stem	cells	176.		Our	data,	as	
well	as	other	studies,	report	a	significant	decline	in	WNT	signaling	proteins	involved	in	the	proliferation	
of	neural	progenitor	cells	in	the	aged	hippocampus	180.		What	our	study	was	able	to	further	reveal	was	
that	treatment	with	polyphenolic	compounds	improve	WNT	signaling	in	aged	animals	and	likely	
contributes	to	the	increase	in	neurogenesis	observed.		What	we	were	unable	to	determine	was	how	
much	influence	microglia	had	in	the	aged	condition	as	well	as	in	our	treatment	condition.		While	it	is	
widely	accepted	that	inflammatory	cytokines	decrease	neurogenesis,	it	is	unclear	whether	they	act	
directly	on	the	WNT	pathway	or	if	there	are	cell-autonomous	events	that	contribute	to	the	decline	in	
WNT	signaling.		The	second	panel	of	genes	studied	was	of	inflammatory	cytokines,	chemokines,	and	
intracellular	mediators	of	the	inflammatory	process.		As	previously	stated	age	animals	had	higher	levels	
of	pro-inflammatory	genes,	a	trend	reversed	by	the	NT-020	formula.		One	goal	of	the	study	was	to	use	
ingenuity	pathway	analysis	to	try	and	identify	a	target	or	set	of	targets	for	NT-020.		Ultimately,	a	panel	
limited	almost	exclusively	to	downstream	cytokines	and	intracellular	kinase	gene	expression	was	not	
able	to	provide	a	clear	answer.		Also,	do	to	limitations	of	the	experimental	model	there	was	no	way	to	
hold	inflammation	steady	and	examine	the	effect	of	NT-020	exclusively	on	neural	stem	cells.		However,	
unpublished	data	from	our	lab	suggests	that	the	formula	does	indeed	have	cell-autonomous	effects	that	
promote	proliferation	and	resistance	to	oxidative	stress.		The	latter	observation	was	also	confirmed	in	
our	published	work	as	shown	by	the	upregulation	of	the	protein	NRF2	in	cells	treated	with	NT-020.				In	
the	brain	stem	cells	can	go	down	a	glial	or	neuronal	lineage	and	as	the	brain	ages,	the	glial	lineage	tends	
to	predominate.				This	shift	is	important	because	it	removes	the	risk	associated	with	artificial	
enhancement	of	aged	stem	cell	proliferation	while	still	increasing	the	available	population	of	neuronal	
stem	cells.		Our	data	suggests	that	treatment	with	NT-020	increases	expression	of	transcription	factors	
associated	with	neuronal	lineage	commitment.	Whether	there	is	some	sacrifice	of	function	due	to	the	
loss	of	glial	progenitors	is	currently	unknown.		The	increase	in	oligodendrocytes	may	be	necessary	to	
counteract	the	age-dependent	increase	in	demyelination.		It	may,	however,	be	just	as	likely	that	the	
increase	in	glial	progenitor	proliferation	occurs	simply	as	a	response	to	the	enhanced	inflammatory	
environment	present	in	the	aged	brain.		While	our	results	suggest	changes	in	transcription	factor	activity	
because	the	experiments	were	limited	to	gene	expression	we	are	unable	to	query	as	to	the	mechanisms	
by	which	these	changes	in	expression	occurred.		It	is	possible	that	simply	through	a	change	in	redox	
status	polyphenolic	compounds	can	affect	the	activity	of	a	wide	number	of	kinases	through	post-
translation	modification.		So-called	“redox”	switches	on	proteins	consist	of	cysteine	and	acetyl	groups	on	
proteins	that	can	be	modified	by	oxidative	or	reduced	conditions	in	a	cell.		These	switches	are	present	
on	several	cellular	sensors	of	stress	including	the	oxidative	stress	sensor	NRF2.		While	no	exhaustive	
study	of	these	“switches”	has	been	performed	they	present	one	potential	mechanism	by	which	simply	
altering	the	redox	status	of	a	cell	can	impact	gene	expression.			Polyphenols	hold	great	promise	in	the	
realm	of	neuroprotection.			NT-020	is	a	proof	of	concept	that	polyphenolic	compounds	are	capable	of	
modulating	several	age	relevant	targets	simultaneously	and	improve	phenotype	with	minimal	risk	of	
side	effects.		Phenotypic	screening	of	compounds	is	a	powerful	translational	tool	to	quickly	identify	
promising	compounds	for	the	treatment	of	a	particular	disease.		This	approach	is	made	difficult	in	
complex	systems	and	diseases,	particularly	ones	that	include	cognitive	function.		Increased	neurogenesis	
in	culture	does	not	necessarily	translate	to	improved	behavior	at	the	organism	level,	and	may	not	be	
necessary	at	all	for	behavioral	improvements	to	be	observed.		Studies	like	the	one	discussed	here	plainly	
point	out	both	the	targets	in	aged	cells	as	well	the	sufficient	number	of	pathways	that	must	be	
modulated	for	therapeutic	benefit.		This	means	that	phenotypic	testing	can	be	done	at	the	molecular	
level	with	results	that	should	be	directly	translatable	to	behavior.	
What	the	previous	study	lacked	was	the	ability	to	observe	changes	that	went	beyond	gene	
expression.		So	it	was	followed	up	by	a	mass	spectrometry-based	proteomic	experiment.		This	method	
gives	researchers	the	ability	to	study	changes	in	protein	abundance	that	may	occur	for	reasons	beyond	
simple	changes	at	the	transcriptional	level.		Often,	proteins	are	regulated	by	post-translational	
modifications	that	change	turn-over	rates	or	stability.		Furthermore,	multi-unit	complexes	that	make	up	
the	majority	of	signaling	complexes	in	the	cell	can	be	affected	by	changes	in	abundance	of	one	or	more	
component.		In	addition,	the	follow-up	study	focused	exclusively	on	the	microglial	cell	vs	a	tissue	
homogenate.		The	microglial	cell	is	remarkable	in	terms	of	its	capacity	to	respond	to	a	wide	array	of	
unique	stimuli	with	such	discreet	states	of	activation.		The	“activation	state”	of	a	microglia,	in	fact,	
cannot	be	viewed	in	isolation	as	its	dynamic	interactions	with	other	cell	types	in	its	environment	add	an	
additional	layer	of	regulation	and	complexity	to	their	behavior.		For	example,	increased	neuronal	activity	
can	trigger	the	release	of	IL1β	and	IL6	which	can	enhance	LTP,	while	in	another	context	or	at	different	
concentrations	these	same	substances	can	be	neurotoxic	48,249.		Neurons	produce	microglial	modulating	
proteins	that	can	either	be	anchored	to	the	cell	or	cleaved	and	become	soluble.		Two	known	proteins	
are	CD200	and	Fractalkine	48.		From	development	till	death	the	microglia	are	central	the	proper	
functioning	of	the	brain's	most	important	structures.			To	this	point	little	was	known	about	how	the	
cellular	systems	of	microglia	were	affected	by	age.		Ample	research	exists	on	the	phenotype	of	aged	
microglia	and	more	studies	examining	their	changes	throughout	life	are	beginning	to	be	published.		
What	we	know	to	this	point	is	that	microglia	begin	to	exhibit	an	aged	phenotype,	that	while	having	some	
parody	with	peripheral	macrophages,	has	enough	unique	characteristics	to	warrant	their	own	study.		
While	macrophages	in	the	periphery	exhibit	a	type	of	senescence	and	diminished	response	to	insult,	
microglia	become	“hypersensitive”	or	primed.		This	observation	must,	however,	be	taken	in	context.		
Microglia	in	a	healthy	brain,	are	generally	less	robust	in	terms	of	the	inflammatory	response	than	
macrophages	88.		They	are	maintained	in	what	has	been	termed	a	“resting	state”	by	the	action	of	
receptors	like	CD200	and	CX3CR1	105.			The	maintenance	of	this	surveilling	state	is	lost	with	age	as	an	
expression	of	both	CD200	and	CX3CR1	are	diminished.		This	likely	contributes	to	the	increase	in	pro-
inflammatory	cytokine	release	exhibited	with	age	as	well	as	the	apparent	loss	of	coordination	between	
immune	and	non-immune	cell	types	in	the	brain.				
Chapter	4	details	a	proteomic	analysis	of	the	aged	microglia	and	identifies	changes	in	key	pathways	that	
are	upstream	of	important	microglial	functions.		The	phenotype	of	microglia	are	inextricably	linked	to	
the	sensing	of	their	environment.		Their	ability	to	monitor	their	own	cellular	state	ensures	the	proper	
resources	for	polarization	are	available.		An	acute	inflammatory	response	results	in	rapid	expansion	of	
microglia,	migration	to	a	site	of	injury,	and	release	of	high	amounts	of	reactive	oxygen	and	nitrogen	
species.		This	is	both	incredibly	energy	intensive	and	stressful	for	the	microglia	itself.	High	amounts	of	
precursors	are	necessary	for	cell	division	and	an	up-regulation	of	enzymes	is	vital	for	protecting	the	cells	
from	oxidative	damage.		Complicating	this	increased	energy	demand	is	the	fact	that	upregulation	of	
NADPH	and	production	of	ROS	temporarily	impairs	the	electron	transport	chain	250.		To	compensate	cells	
rely	on	aerobic	glycolysis,	a	switch	which	is	dependent	upon	the	activity	of	protein	C-MYC	and	mTOR	
upstream	of	that	80.		It	is	here	our	proteomic	screen	identified	significant	changes	with	age.		The	
metabolic	systems	required	to	maintain	proper	microglial	function	are	governed	by	a	network	of	
nutrient-sensing	kinases	that	regulate	metabolism	and	cell	growth.		Specifically,	the	mTORC2	branch	of	
the	mTOR	pathway	was	shown	to	have	diminished	activity	in	aged	microglia.		This	is	highly	significant	
because	the	mTOR	pathway	has	a	reciprocal	signaling	propensity	which	relies	on	feedback	from	both	the	
mTORC1	and	mTORC2	complexes	to	balance	the	total	output	of	the	pathway.		Too	much	mTORC1	
signaling	should	theoretically	feedback	to	the	cell	surface	and	deactivate	IRS1	blocking	the	ability	of	
insulin	to	transduce	a	signal	throughout	the	cell.		This	mechanism	of	over-activation	of	mTORC1	is	one	
hypothesized	contributor	to	the	insulin	resistance	that	occurs	with	age.		MTORC2	itself	is	upstream	of	
AKT	but	may	also	exert	influence	over	the	sirtuins	and	FOXO	family	of	proteins	251.		Our	results	indicate	
that	aged	microglia	are	utilizing	fatty	acids	and	amino	acids	as	an	energy	source	in	the	aged	brain.		This	
is	consistent	with	an	over-activation	of	mTORC1	which	through	the	blockade	of	IRS1	could	prevent	the	
cells	ability	to	take	up	glucose.		One	potential	cause	of	increased	mTORC1	is	a	diminished	mTORC2	
activity	which	can	act	as	a	negative	feedback	to	its	counterpart	234.		However,	diminished	mTORC2	
activity	could	just	as	easily	be	a	result	of	impaired	upstream	kinases	in	PI3k	family	which	may	also	be	
susceptible	to	over-activation	of	mTORC1.		Thus	our	finding	could	either	be	causative	or	an	effect	of	a	
tangential	disruption.		In	either	cause,	the	consequences	of	this	decrease	in	the	activity	feed	down	into	
important	microglial	functions.		When	mTORC2	is	knocked	down	using	siRNA,	microglia	exhibit	a	
hypersensitive	phenotype	similar	to	that	of	aged	cells.		While	our	study	did	not	specifically	examine	a	
particular	mechanism	by	which	this	occurs,	it	is	nonetheless	a	promising	result.		The	objective	of	the	
study	as	previously	was	to	identify	at	the	very	least	a	set	of	cellular	systems	that	if	modulated	in	some	
way	would	provide	a	means	by	which	we	could	attenuate	the	more	harmful	consequences	of	cellular	
aging.		The	mTOR	pathway	has	been	studied	for	over	40	years	resulting	in	a	multitude	of	compounds	
targeting	various	aspects	of	its	activity.		If	we	are	subsequently	able	to	identify	the	particular	
downstream	interaction	responsible	for	the	effects	that	were	seen	in	our	study	we	may	be	able	to	find	a	
particular	molecule	suitable	for	modulating	that	interaction.		The	same	cannot	be	said	for	proteins	like	
C-MYC	whose	interaction	is	heavily	dependent	on	co-transcription	factors.	Also,	given	the	breadth	of	the	
network	downstream	of	C-MYC,	it	seems	unlikely	that	by	altering	any	particular	interaction	we	would	be	
able	to	substantially	alter	the	observed	phenotype.			
Another	finding	central	to	furthering	our	understanding	of	the	aged	microglial	cell	was	the	presence	of	
high	levels	of	myelin	oligodendrocyte	basic	protein	Chapter	4.		This	is	the	major	component	of	the	
myelin	sheaths	that	protect	neuronal	axons	throughout	the	CNS.		The	breakdown	of	myelin	with	age	is	a	
well-studied	phenomenon	whose	etiology	is	not	fully	resolved.		Whether	there	is	an	inflammatory	
component	to	the	process	is	not	fully	known,	but	the	involvement	of	microglia	in	the	later	stages	of	the	
degradation	is	well-established.		Microglia,	unlike	macrophages,	are	long-lived	and	while	some	do	die	
after	inflammatory	events	their	population	is	maintained	consistently	up	until	the	later	years	in	life	
121,125.		At	this	point,	the	numbers	of	microglia	in	various	areas	of	the	brain	increase	and	they	tend	to	lose	
their	uniform	distribution	and	form	clumps	or	patches	121.		This	behavior	has	been	observed	to	a	large	
degree	in	the	white	matter,	supporting	the	idea	that	microglial	activity	is	at	least	in	part	responsible	for	
accelerated	demyelination	with	age	3.		Due	to	their	long-lived	nature,	microglia	have	a	limited	
phagocytic	capacity	and	lipid-rich	inclusions	have	been	observed	in	the	cytosol	of	aged	microglia.		
Coupled	with	defects	in	autophagy,	due	in	part	to	dysfunction	in	pathways	like	mTOR	discussed	above,	
microglia	can	become	senescent	after	repeated	demyelination	events	22.		The	“Randle-cycle”	is	a	term	
that	describes	a	cell's	propensity	to	use	whatever	the	most	abundant	source	of	energy	in	its	immediate	
surroundings	may	be.		While	there	is	yet	a	definitive	connection	it	is	intriguing	to	think	that	rapid	
demyelination	may	be	responsible	for	the	utilization	of	fatty	acids	observed	in	aged	microglia.		Thus	the	
disruption	in	metabolic	function	in	microglia	may	be	a	result	another	consequence	of	aging,	the	
progressive	loss	of	myelin	in	the	white	matter.	
The	data	presented	in	this	information	is	the	culmination	of	amazing	collaborations	among	researchers	
from	several	specialties.		Interdisciplinary	scientists	in	chemistry,	virology,	genetics,	and	proteomics	
contributed	to	the	insights	discussed	in	this	dissertation.		Age	and	mortality	are	beyond	the	scope	of	the	
science	discussed	here.	However,	this	dissertation,	like	most	scientific	inquiry	presents	as	many	
questions	as	answers.		The	clusters	identified	in	chapter	4	are	certainly	not	unique	to	aging	microglia.	
Does	this	support	the	theory	that	the	molecular	changes	that	occur	with	have	a	high	degree	of	
commonality	throughout	tissues?		Certainly,	manipulating	mitochondrial	function	in	any	cell	will	result	in	
deleterious	effects	but	is	this	enough	to	conclude	causation?		The	conclusions	from	chapter	4	suggest	
that	the	answer	is	likely	not	that	simple.		While	altered	mTOR	signaling	and	mitochondrial	function	
contribute	to	microglial	dysfunction	there	must	still	be	an	extracellular	influence,	be	it	dying	neurons,	or	
accumulated	amyloid	to	trigger	a	phenotypic	shift.	A	current	debate	in	the	field	of	aging	is	whether	or	
not	age	is	a	set	of	“programmed”	adaptive	changes	meant	to	protect	the	organism	at	the	expense	of	
some	tissue	function.		If	in	fact	microglia	shift	from	glucose	to	fatty	acid	metabolism	with	age,	this	would	
represent	one	example	of	an	adaptive	response,	but	whether	or	not	it	is	pre-programmed	or	a	response	
to	the	environment	cannot	be	concluded	from	our	data.		However,	if	our	data	correctly	describes	the	
changes	within	nuclear	architecture	and	the	chromatin	remodeling	complex	than	a	third	hybrid	theory	
can	be	introduced.	While	it	is	unlikely	the	observed	changes	are	programmed	they	may,	in	fact,	be	a	
direct	result	of	a	loss	of	transcriptional	control.		Large	subsets	of	genes	are	regulated	through	the	
maintenance	of	heterochromatin	in	the	nucleosome.		As	histone	composition	changes	in	the	aged	cell	so	
do	the	chromatin	structure.		To	elucidate	this	fully,	it	would	be	necessary	to	map	the	genes	at	sites	
where	the	chromatic	structure	is	significantly	affected	by	age,	to	confirm	if	those	genes	correlate	to	the	
differentially	regulated	systems	observed	in	age.	These	studies	have	in	fact	already	begun	within	the	
realm	of	systems	biology	where	modeling	of	complex	biological	interactions	is	currently	underway.				
Another	relevant	question	that	should	be	addressed	in	any	conclusion	in	a	straightforward	and	concise	
manner	is	“What	now?”.		Given	the	ability	of	new	technology	like	the	kind	described	in	this	discussion	it	
is	likely	that	new	models	of	microglial	behavior	begin	to	emerge.		An	interesting	question,	is	how	closely	
are	the	changes	we	observed	tied	to	the	response	of	microglia	to	stimuli?		Or	is	there	a	tipping	point	at	
which	inflammatory	cytokines	begin	to	antagonize	the	WNT	pathway?		High-throughput	techniques	like	
flow	cytometry	allow	for	the	simultaneous	observation	of	multiple	variables	and	can	provide	the	
backbone	for	such	models.		The	field	must	also	begin	to	take	much	more	seriously	the	question	of	the	
microglia	and	its	many	facets	of	activation.		Here	again,	high-throughput	models	that	examine	the	effect	
of	100’s	of	combinations	of	molecules	and	concentrations	on	microglia	phenotype	can	be	performed.		
We	currently	lack	a	good	baseline	for	the	microglia	cell,	which	makes	the	task	of	identifying	pathological	
states	that	much	more	difficult.		Another	recurring	difficulty	that	presented	itself	during	this	study	is	a	
lack	of	dependable	data	on	microglial	response	to	stimulation.		While	some	studies	observed	10	to	20	
fold	changes	in	a	given	protein,	another	publication	with	similar	methods	would	report	a	fold	change	in	
the	thousands.		If	the	response	is	indeed	that	heterogeneous	within	the	population,	then	perhaps	more	
genomic	work	is	warranted	to	parse	out	specific	alleles	responsible	for	these	differences.		Omics	studies	
are	continuing	to	show	their	utility	in	translational	science	by	providing	targeted	insight	into	complex	
systems	with	an	accuracy	not	previously	possible.		They	will	continue	to	be	a	powerful	tool	in	the	quest	
to	understand	how	and	why	we	age.		Aging	well	is	a	result	of	luck,	effort,	and	environment,	through	the	
efforts	of	my	P.I.	and	team	mates	I	am	confident	that	the	work	presented	here	reduces	by	just	a	little	
the	role	of	luck	in	the	process.	
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